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Abstract
H-D exchange at the formyl residue of the natural product malonganenone B was in-
vestigated. Models of the system were synthesised and displayed the same exchange.
Kinetic studies, performed using NMR spectroscopy, found the exchange was first
order with respect to base whilst displaying acid inhibition, in opposition to exist-
ing research. Cyclic species, including an N-heterocyclic carbene precursor, were
formed that, in conjunction with the previous findings, suggested a carbene-based
mechanism was in operation. Further synthetic studies were performed to demon-
strate the existence of a carbene. With use of silver oxide, a fulvalene dimer and
an organopalladium complex of this carbene were obtained, which provide further
support towards a carbene-based mechanism being involved in the H-D exchange of
malonganenone B.
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Chapter 1
Introduction
1.1 Malonganenone B and H-D exchange
Two related families of natural products have been reported from African gorgonian
species. Gorgonians (order Gorgonacea of the phylum Cnidaria) are commonly
known as sea fans or sea whips. The gorgonian Leptogorgia gilchristi, collected from
a reef near Ponto Malongane, Mozambique, yielded three novel prenylated alkaloids,
malonganenones A (1), B (2) and C (3).1 These bear the same tetraprenyl chain,
but differ in their head groups; malonganenone A features a hypoxanthine moiety, B
a substituted imidazole system and C a simple formamide. These compounds were
re-isolated from a different gorgonian, Euplexaura nuttingi, from Uvinage, Pemba
Island, Tanzania, alongside malonganenones D-H (4–8) and the nuttingins A-F (9–
14).2 The later malonganenones differ in their tetraprenyl tail, whereas the nut-
tingins feature different purine-based alkaloid heads but with the same range of
tails. Malonganenones A-C were found to exhibit moderate cytotoxic effects against
oesophageal cancer,1 which is a major health concern in southern Africa.3 Simi-
larly, malonganenones D-H and the nuttingins were tested for activity against both
K56224 and UT725 human leukaemia cell lines, for which they demonstrated mod-
erate inhibitory action on cellular proliferation.2
The structural elucidation of malonganenone B was particularly problematic. Mass
spectral analysis, which followed NMR acquisition in methanol-d4, resulted in two
strong molecular ion peaks, the difference between which was substitution of a proton
for a deuteron (m/z 471.3335 and 472.3398, respectively).1 Comparison of the 1D
and 2D NMR data with malonganenones A and C suggested they share the same
tetraprenyl chain but B instead bears an imidazole ring with N -methylamide and N -
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methylformamide substituents. The data suggested the presence of two isotopomeric
carbonyls at the formamide, which, in addition to the lowered proton integration
at this position and the presence of a deuterated analogue as indicated by MS,
suggested that the formamide proton, rather than the N -H of the methylamide, had
exchanged for a deuteron whilst dissolved in methanol-d4 [Scheme 1.1]. In support
of this, a sample exposed to methanol for a number of days showed full return of
the proton integration at the formyl position by 1H NMR.
Hydrogen-Deuterium (H-D) exchange is a well known phenomenon, but not with
these conditions or functionalities. H-D exchange is an established field utilised
in the production of isotopically-labelled standards for use in studies elucidating
mechanistic theories or C-H bond activation.4,5 These studies rely upon establish-
ment of an equilibrium between the carbon-bound protons and the deuterons in the
reagents, whereupon there is a drive for preferential formation of a C-D bond over a
C-H bond. This is due in part to the increased stability of a C-D bond arising from
the greater mass of a deuteron lowering the vibrational frequency and hence lower-
ing the zero point energy. However, the preference in these reactions mainly exists
due to the large excess of deuterium from the solvent compared to protons from
the reactant driving the equilibrium. These reactions usually involve acid, base or
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Scheme 1.1 H-D exchange at the formyl centre of malonganenone B
metal catalysis. With malonganenone B, however, this occurs in methanol-d4 with
a notable absence of any of the aforementioned catalytic species. In addition, these
exchanges usually occur at positions on pi-ring systems or at the α- or β-positions
of carbonyl functionalities; however, exchange in species similar to malonganenone
B has been reported once before, also in the absence of any notable catalysts, by
Simchen & co-workers at the University of Stuttgart.
1.2 Simchen’s work on the H-D exchange of N,N -
dialkylformamide acetals
As with many discoveries in science, this curious H-D exchange was serendipitously
found. Following previous findings that chloroform readily exchanges its proton
in the presence of a base6 but that orthoformate esters do not,7 Simchen and co-
workers began investigating electrophilic substitution at the formyl carbon of or-
thoformamides via the acidity of the formyl proton through base-catalysed H-D
exchange.8 During this work, it was found that N,N -dimethylformamide acetals
exchanged their formyl protons in deuteroalcohols without any catalyst. A corre-
lation was found that increasing the alkyl chain length, and hence acidity, of the
deuteroalcohol decreased the rate of exchange.
This initial work was followed with a more comprehensive study, in which Sim-
chen investigated the H-D exchange of a number of derivatives to probe the mecha-
nism in operation. The study was based around the compound dimethylformamide
dimethylacetal (DMFDMA, 15), where it was found that increasing the alkoxy chain
length, and hence the pK a of the resultant alcohol, led to a decrease in H-D exchange,
in contrast to an initial increase in rate with increasing length of the nitrogen-alkyl
3
chains. A decrease in rate with larger nitrogen-alkyl chains was attributed to com-
peting steric factors at the nitrogen centre. Derivatives with cyclic-nitrogen substi-
tution were synthesised, for example the piperidine derivative 16, which showed a
decrease in exchange compared to the original methyl model. Cyclic acetals, 17,
were also synthesised, but no H-D exchange occurred provided the ring did not open.
To specifically probe a carbene mechanism, carbene-precursor iminium compounds,
e.g . 18, were made which also did not exhibit any H-D exchange, even upon heat-
ing and addition of base, to facilitate removal of the proton to form the carbene.
Due to the fact that protons shift repeatedly in this exchange, kinetic studies in
the presence of exogenous bases, such as sodium methoxide and triethylamine, were
performed. Addition of an exogenous base was found to inhibit H-D exchange at
the formyl centre, which was critical in elucidating the mechanism of this exchange.
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Based on these results, Simchen proposed three mechanisms for the H-D exchange.9
The three proposed were [Scheme 1.2]; a. a carbene mechanism in which nitrogen-
assisted elimination of an alkoxy group precedes removal of the formyl proton, gen-
erating a carbene that may then extract a deuteron from the solvent; b. a self-
protonation mechanism in which the nitrogen of one molecule abstracts the formyl
proton of another, similarly followed by deuterium-quenching of the resulting car-
banion; c. a mechanism in which deuteration of the nitrogen and solvent abstraction
of the formyl proton, concerted or stepwise, generates an ylide, which undergoes ei-
ther a 1,2-deuterium shift or incorporation of a deuteron from the solvent.
The findings were interpreted by Simchen as disproving two of the suggested mech-
anisms. In support of a carbene mechanism, the decrease in H-D exchange with
increasing size of the N-alkyl groups was reasoned as due to increasing hindrance
to co-planarity, and that H-D exchange has been seen for related cyclocarbonium
ion species10 and cyclic nucleophilic carbenes.11 It was argued that base would not
influence the reaction due to a balance between the effects on the dealkoxylation and
deprotonation steps, although this assumes an exact balance and one would expect
that catalysis in the rate-determining step (RDS) would have a larger effect on the
rate. The greatest evidence against this mechanism is that the carbene precursors
did not exhibit H-D exchange. In support of the self-protonation mechanism there
was a positive correlation between exchange and basicity of the nitrogen, reasoned
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Scheme 1.2 Simchen’s proposed mechanisms for H-D exchange
as due to an increase in the rate of self-protonation. But, again, inhibition by an
exogenous base disfavours this mechanism. Technically, other agents should have
no effect as only two acetal molecules are involved in the RDS, however a foreign
base could directly deprotonate the acetal leading to an apparent increase in H-D
exchange, or act to increase the concentration of the free amine by competing for
deuterium ions, which would actually increase the rate.
Simchen concluded from this research that the findings best supported an ylide
mechanism, but this author is sceptical about the assignment. An initial increase
in nitrogen basicity with increasing size of alkyl chain would act to increase the
rate of deuteration, until the size of the alkyl groups became sterically hindering.
The carbene-precursor derivatives could not exchange through this mechanism, in
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correlation with the observations. Most importantly, however, addition of a foreign
base would compete for deuterium with the formyl acetal nitrogen and hence is
the only mechanism that accounts for the observed base-inhibition. Why the cyclic
acetals and nitrogen substituents did not react was discussed but largely unreasoned.
Notwithstanding this, the hypothesis that best fits the available data for the H-D
exchange, according to Simchen, is the ylide mechanism; which may be correct,
when one neglects the base activation in the proposed RDS of this mechanism. In
the opinion of this author, the results of the study were not definative: all the
mechanisms were supported by some of the data, but no mechanism was supported
by all the data. The most conflicting piece of information is the base inhibition as
the two main mechanisms, ylide and carbene, should be base catalysed. Further
investigation is therefore required to confirm the mechanism.
1.3 Kinetic studies
To gain insight into the mechanism, an investigation into the kinetics of the exchange
was required. Of key importance is ascertaining the species involved in the RDS and
their order. This can be done simply by performing kinetic studies and analysing
the rate of exchange with respect to concentrations of the different species.12 For
a generic reaction, such as shown in Equation 1.1, the rate is equal to the rate of
change of concentation of each species involved proportional to their stoichiometry
[Equation 1.2]. This generic reaction would give rise to a rate law of the form such
as Equation 1.3, where the rate is dependent on the concentration of each species
to the power of its stoichiometry in the RDS. A number of manipulations of these
simple equations are available to allow mechanistic data to be found experimentally.
nA+mB → xX + yY (1.1)
rate = − 1
n
dA
dt
= − 1
m
dB
dt
=
1
x
dX
dt
=
1
y
dY
dt
(1.2)
rate = k[A]n[B]m (1.3)
The order of a species in a reaction can be obtained from analysis of the initial rate
of reaction. The Initial-Rate method is based upon the approximation that over
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the first 10% of change in a reaction, the rate of change of a species with time can
be approximated by the rate of change of concentration of that species [Equation
1.4]. Applying a linear model to the change in concentration with time gives an
estimate of the initial rate. If the rate is measured at two different concentrations
of a molecule, while other species are held constant, Equations 1.5 and 1.6 can
be defined to describe these situations, which can be combined and have common
factors eliminated to give Equation 1.7. As can be seen, taking the logarithm of this
equation, Equation 1.8, would result in a plot of log(r1/r2) against log([A]1/[A]2)
having a straight line of slope n, where n is the order of the species investigated.
This method has certain advantages in that complex rate equations can be simplified
easily and the orders obtained. However, fitting a linear model to obtain the initial
rate is affected hugely by any delay to the acquisition of data. Similarly, the fact
that a linear model is being applied to an exponential curve means that the data is
not always accurate. Finally, this method only allows two sets of data to be used
at any one time and an array must be used to generate enough data points to be
confident of any result.
− dA
dt
' −∆A
∆t
(1.4)
r1 ' −(∆A/∆t)1 = k[A]n1 [B]m (1.5)
r2 ' −(∆A/∆t)2 = k[A]n2 [B]m (1.6)
r1/r2 = ([A]1/[A]2)
n (1.7)
log(r1/r2) = nlog([A]1/[A]2) (1.8)
An alternative method to obtain this data is by measuring the half-life. The half-life
is the time required for the concentration of a species from any point to decrease by
a half. Applying an exponential model to the concentration of species in the reaction
with time allows the κ value to be obtained [Equation 1.9]. Taking the logarithm
of this equation [Equation 1.10], substituting in [concentration] = 0.5 and t = t1/2,
and rearranging, the Equation 1.12 can be obtained. Substituting in the κ value
7
obtained for a particular kinetic experiment allows the half-life to be calculated. The
Half-Life method can then be used to investigate the half-life as a function of initial
concentrations. If the concentration of all other species are kept constant, then the
rate law Equation 1.3 becomes Equation 1.13, with a new k’ value that incorporates
[B]m. Integrating this equation and substituting in A = Ao/2 and t = t1/2, the
Equation 1.14 can be obtained, the logarithm of which can be rearranged such that
plotting logt1/2 against logAo should describe a straight line of slope (1−n) [Equation
1.15]. Provided data is collected over a number of half-lives, this provides a more
accurate assessment of order than the Initial-Rate method. However, if the H-D
exchange for a particular analyte is too long, this method becomes impractical.
[concentration] = exp−κ.t + c (1.9)
log([concentration]) = −κ.t+ c′ (1.10)
log(2) = κ.t1/2 (1.11)
t1/2 = log(2)/κ (1.12)
− dA
dt
= k′[A]n (1.13)
t1/2 =
2n−1 − 1
(n− 1)kAn−1o
(1.14)
logt1/2 = (1− n)logAo + C (1.15)
1.4 N-heterocyclic carbenes
The area of carbene chemistry has been greatly explored since Simchen’s work was
completed.13 The concept of divalent, uncharged carbon atoms, or carbenes (19), in
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a molecule was first suggested in 1855 by Geuther and Hermann.14 Their work was
carried along over the following century by research into radicals, where carbenes
were treated as diradicals, but there was only a true resurgence in the area following
Doering’s demonstration in 1954 of a dibromomethylene intermediate in the alkaline
hydrolysis of bromoform.15 In this work a carbene was trapped with an alkene in a
new cyclopropanation reaction, the first demonstration of a carbene. Much work has
gone into their geometric and electronic properties.16 These can be either triplets
or singlets, with a lone pair or two singly-occupied orbitals respectively, which are
strongly influenced by any α-substituents. These substituents also dictate whether
the carbene is electrophilic or nucleophilic.
R R'
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Carbenes can undergo a range of different reactions to generate a number of differ-
ent species. Cyclopropanation reactions with carbenes are of historical importance
as this was used to first prove their existence.15 The mechanism of this reaction
is dependent upon the nature of the carbene; triplet carbenes react through two
radical steps and therefore give a mixture of cis and trans isomers, whereas singlet
carbenes react in a single pericyclic step to give only the cis product [Scheme 1.3.a].
As with most reactions, matching the energy of the alkene to that of the carbene
R
R'R
R'
R
R'R
R'
R
R'R
R' R
R'R
R'
R
R'R
R'
R R'
R R'
R R'
R R'
b. Dimerisation
c. Organometallic complexes
a. Cyclopropanation
R R' M
R R'
M
R R'
M
or
Scheme 1.3 Some general reactions of carbenes
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is of crucial importance. Carbenes can alternatively react with themselves to form
dimers [Scheme 1.3.b]. Each carbene has an unoccupied orbital, no formal charge
to repel the other and have high reactivity, plus strong carbon-carbon double bonds
are the outcome of such dimerisation. As they are identical in energy, matching of
HOMO and LUMO levels for singlet-carbene dimerisation is not possible; however,
the SOMO levels of the diradical triplet carbenes match exactly and have good or-
bital overlap. As a result, it is expected that triplet carbenes dimerise faster than
singlets. The most recent development is the use of carbenes as organometallic lig-
ands [Scheme 1.3.c]. When binding to metals, the carbene centre is stabilised either
by back-donation from the metal or by lone pairs of the α-substituents. Historically,
these complexes have not been that stable.
N N R'''
R''
R
R'
N N
Ru
P(Cy)3PhCl
Cl
N N
20 21 22
This changed with the development of N-heterocyclic carbenes (NHCs) (20). Car-
benes with two amino substituents were first proposed at the time of Simchen’s
investigations by O¨fele and Wanzlick in 1968.17,18 The field was largely ignored,
however, until Arduengo demonstrated the first instance of a stable free NHC,
the diadamantyl-substituted imidazolylidene 21.19 NHCs typically form singlet car-
benes, due to stabilisation of the empty carbon p-orbital from overlap with the
lone pairs of the nitrogen atoms. This intramolecular stabilisation of the carbenic
center helps to prolong the lifetime of NHCs. In addition, the two nitrogen sub-
stituents, through electron-donation, mean NHCs are quite nucleophilic. Although
many methods to prepare these are known,13 they are most commonly synthesised
from the corresponding imidazolium salt that is deprotonated to give the free NHC,
as occurs in the synthesis of Grubbs’ 2nd generation catalyst (22) [Scheme 1.4].20
This example highlights the main area in which NHCs are employed: as organometal-
lic ligands.
N NR R'
Cl
N NR R'
Grubbs' 1st 
Generation Catalyst N NR R'
Ru
Ph
PCy3
Cl
Cl
H
NaH
22
Scheme 1.4 Synthesis of Grubbs’ 2nd generation catalyst
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NHCs have found large application in organometallic chemistry. They are alter-
natives to phosphine ligands that can be less sensitive to air, water, silica and
oxidation, as well as having stronger binding to metal centers.21–23 They typically
form strong σ-bonds with metals with little back-donation due to the stabilisation
of the carbene center by the lone-pairs of the nitrogen atoms.13 Slight changes to
the substituents of the NHC can have notable effects on their electronic and geo-
metric properties, allowing these to be used to tune the properties of the complex.
Furthermore, they usually act as spectator ligands, therefore these effects can last
throughout a catalytic cycle. Many organometallic complexes with NHC ligands
have now been produced and used in catalysis,24–28 the most note-worthy example
of which is Grubbs’ second generation catalyst.20
1.5 Intended Research
Investigations into the H-D exchange of malonganenone B were based on the mech-
anisms of Simchen and the more recently acquired knowledge on NHCs. To obtain
a species similar to that upon which Simchen’s mechanisms were based requires an
initial cyclisation event [Scheme 1.5]. This would be expected to result from the
attack of the amide nitrogen on the formamide moiety, generating an aminal ester.
The nitrogen is expected to attack rather than the oxygen, based on the increased
nucleophilicity and by comparison to existing natural compounds such as caffeine.
From this point it is expected that the mechanism would proceed either through the
ylide or carbene mechanism (the self-protonation mechanism is treated as a variation
of the ylide mechanism). To try and probe which mechanism is occuring in the H-D
exchange, kinetic and synthetic studies were to be performed. Synthesis of models
of malonganenone B were to be conducted and kinetic studies performed on these
compounds using NMR spectroscopy. The order of the reaction with respect to all
species involved was to be obtained and confirmation of Simchen’s base “inhibition”
would be sought. Once the mechanism was putatively assigned, conclusive proof
was to be sought through the trapping and demonstration of key intermediates.
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Chapter 2
Synthetic and kinetic
investigations
2.1 Imidazole-based models
2.1.1 Synthesis of imidazole-based models
To analyse the H-D exchange of malonganenone B, an analyte was first required.
Given that only 14 mg of malonganenone B (2) was originally isolated,1 and lacking
the resources to go diving off the coast of Mozambique to collect more, the com-
pounds to be studied were synthesised. Rather than devise and complete the total
synthesis of malonganenone B (to date none of the malonganenones or nuttingins
have been synthesised), a simpler model was proposed. 4-[Formyl(methyl)amino]-
N,1-dimethyl-1H -imidazole-5-carboxamide, 23, differs only in that a methyl group
replaces the tetraprenyl tail of malonganenone B at the 1-position of the imidazole
ring. As the tail was not believed to be involved, but that the unique, substituted
imadazole of malonganenone B was accurately replicated, it was expected that this
would exhibit the same H-D exchange.
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Scheme 2.1 Mechanism of the ring-opening of caffeine
Given the similarities between the target compound and caffeine (24), this appeared
as the ideal starting material. Hydroxide can be used to attack the carbamide center,
which is the most electrophilic carbonyl due to the two electron-withdrawing nitro-
gen atoms attached [Scheme 2.1].29 When the carbonyl of species 25 reforms, the
bond to the amide breaks selectively because the resultant amide can better stabilise
the charge through resonance than the amine if the alternate bond where to break.
The resulting carbamate 26 decarboxylates in the presence of base to give 27. Un-
fortunately, this reaction is usually performed on substituted purines with alkyl tails
that allow a handle for separation. Given the presence of basic functionality in the
form of a secondary amine and an imidazole ring, the possibility of hydrogen-bonding
between the amine and amide generating a dipole, plus the possibility of a charged
resonance form involving the amine, amide and imidazole, it is not surprising that
this molecule was too polar for standard organic synthetic purification techniques
to be used. Extraction with many organic solvents was unsuccessful, including,
but not limited to, liquid/liquid partitions, solid/liquid extractions and continuous
liquid/liquid extraction. Eventually a reverse-phase chromatographic method was
utilised to yield 27 [Scheme 2.2]. Subjecting this compound to refluxing formic acid
led to acid-catalysed formamide formation on the secondary amine to afford 23 as
an impure solid.30 Formylation of the amine had only a limited effect on polarity of
the molecule and purification was still problematic. Eventually, it was found that
recrystallisation from ethyl acetate, on occassion, afforded small crystals of 23.
Having laboured to obtain purification methods, further literature searching revealed
that this synthetic scheme had been completed previously.31 Here, the ring-opening
ON
N
N
N
O
N
N
NH
i or ii
N
N
N
O
H
iii or iv
O
N
H
O
N
H
24 27 23
Reagents and Conditions: i. NaOH, EtOH, H2O, reflux, 3 h, 56%; ii. NaOH, H2O, reflux, 2 h,
37%; iii. Formic acid, reflux, 30 min, 6%; iv. Formic acetic anhydride, rt, 12 h, 51%.
Scheme 2.2 Synthesis of 23
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was again performed with aqueous sodium hydroxide, but nitric acid was then added
to form the nitrate salt, which was empirically found to be insoluble in water. Fil-
tration of the precipitate and equilibration in aqueous potassium carbonate to re-
generate the free amine gave 27 with a higher purity and yield than previously.
Interestingly, from this source the material is soluble in organic solvents, hence able
to be recrystallised, which begs the question of whether it is interactions between 27
and impurities from its synthesis that led to the purification issues. The synthesis
was then completed using formic acetic anhydride as formylating agent, rather than
formic acid, to give 23 in good yield.
2.1.2 Rotamers of 23
Upon first obtaining the NMR spectrum of 23, two sets of resonances were observed.
Solving each set revealed the same chemical connectivity, which suggested that two
conformational isomers were being observed. Given the proximity of the formamide
and methylamide substituents, it was hypothesised that steric hindrance between
these groups could limit rotation around the bonds connecting these to the imidazole
ring. The ratio of the two conformers was found to be solvent dependent [Table 2.1].
Omitting deuterium oxide, it appears there is a relationship between polarity and
the ratio of isomers, with one isomer being favoured with increased polarity. There
was also a noticeable difference in the resonance of the nitrogen-bound proton of the
methylamide substituent, which in chloroform-d was 7.57 ppm for one conformer
and 6.02 ppm for the other. Together, this was interpreted as suggesting one of
the conformers involved hydrogen-bonding between the substituents, which would
be more stabilised and hence favoured by more polar solvents. This is discussed in
more detail in Section 2.2.2.
Table 2.1 Solvent-dependance of rotameric ratio of 23
Solvent Polarity of solvent Ratio (A:B)
CDCl3 4.1 1:1.2
CD3OD 5.1 4.1:1
DMSO 7.2 7.2:1
D2O 9.0 2:1
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2.1.3 Kinetic studies with 23
To be able to perform kinetic studies, methods to follow the H-D exchange are
required. Given that it is the replacement of a proton for a deuteron, 1H-NMR
spectroscopy appeared as the ideal tool; the resonance for the exchanging proton
would decrease with time while the other signals of the molecule would remain
unchanged. In 1H-NMR spectroscopy, the area under a peak is proportional to
the number of protons contributing to that peak in the molecule- comparing the
ratio of the integrals of the signals allows insight into the ratio of protons in the
molecule. To follow the decrease in the formyl peak area, a reference is needed,
the most obvious of which is the other, non-changing resonances of the molecule.
Rather than comparing the formyl integral to a single resonance, the formyl was
compared to the total integral of all other resonances in the molecule for accuracy
purposes. The total integral for all resonances in the analyte were defined as 100,
and the fall in the contribution of the formyl resonance, the formyl integral, was
tracked. This value could be manipulated to be expressed as the change in formyl
integral compared to the average integral for a proton in the rest of the molecule and
potentially normalised to a set value across experiments. However, given that only
rates, and not absolute integral values, were to be compared between experiments,
this represented unneccessary manipulations and the preferrence was to work with
the raw data.
Before 23 could be used as a model for the H-D exchange of malonganenone B,
it was neccessary to ensure that H-D exchange occurred. Joyfully, first exposing
23 to methanol-d4 resulted in the loss of the formyl proton resonance, 8.3 ppm,
with time whilst other peaks remained unchanged, proving the validity of our model
[Figure 2.1]. The decline in the integral for this proton maps an exponential curve
[Figure 2.2]. Only defining the integrals of the analyte could prove problematic
if intermediates, with different resonances, were forming, as the ratio of exchange
might vary between the equilibrium populations. However, no other resonances
were observed, suggesting that these populations are small and make a negligible
contribution to the equilibrium distribution. To explore the possible observation of
intermediates, as evidence towards which mechanism is occurring, variable tempera-
ture 1H-NMR spectroscopic studies were performed. The samples were incubated for
five hours in the respective NMR solvents to allow for establishment of the equilib-
rium populations. However, in both chloroform-d and methanol-d4, at both ambient
temperature and -50 ◦C, no other species were observed, reiterating again that the
intermediates in the exchange are neither formed in high concentration nor have a
long lifetime.
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Figure 2.1 1H NMR spectra of 23 with time in CD3OD
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Figure 2.2 Formyl proton resonance with time for 23 in CD3OD
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The H-D exchange was found to be highly dependent on the source of the ana-
lyte. Early kinetic studies showed a variation in rate that was not correlated to
the changes in concentration. Upon inspection, it was realised that these differ-
ences were instead originating from the source crystal. Comparing the half-life of
23 from different sources, or isolation events, huge differences were observed be-
tween them [Figure 2.3]. Although all sources of 23 were crystalline and had been
recrystallised repeatedly, the level of impurity strongly affected the rate of exchange.
Given the mechanisms were believed to be acid-inhibited in the RDS, variation in
trace amounts of formic or acetic acid from the final formylation step may strongly
hinder, or cease entirely, the exchange. For this reason, only experiments from the
same source could be compared.
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Figure 2.3 Source-dependence of rate of H-D exchange
Kinetic studies investigating the effect of [23] on the rate of exchange yielded in-
teresting results. The rate of H-D exchange was measured across a concentration
range of 20 - 100 mmol/L for 23 [Figure 2.4, Table 2.2]. Inspection of the data
suggested there was a trend towards a faster rate at higher concentrations, but in
reality this is a very small change. Applying a linear model to this data, the change
in rate with respect to concentration is only -7 nmol/L.min, or approximately zero,
suggesting the rate of exchange, and hence RDS, is independent of 23. Were the
RDS the formation of a highly energetic deuterating species that spontaneously
forms in methanol-d4 and only deuterates the molecules studied in this research,
then this would be conclusive evidence. Given the alternative, that our molecule
is actually involved in the RDS and some more normal deuterating agent, such as
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Figure 2.4 Concentration-dependence of rate of H-D exchange of 23
Table 2.2 Analysis of concentration-dependence of rate of H-D exchange with a
linear model
Parameter Value
Gradient -0.0000069
R2 0.79496
methanol-d4, is used, it was concluded the data was misleading. It is known that for
any reaction, there is a concentration above which the reaction rate is constant and
becomes limited by other steps or processes. This reflects a saturation of reagents or
a maximal concentration of charged intermediates, such that the generation of more
is inhibited. The solution to this kinetic problem is to assay at lower concentrations,
such that the rate is analysed under unsaturated conditions.
The effect of base on the rate of H-D exchange was investigated with conflicting
results. Simchen & co-workers reported that the addition of an exogenous base
had the effect of inhibiting H-D exchange, whereas acid appeared to be activating.
However, they had a difficult time reconciling this with their proposed mechanisms,
as both the ylide and carbene mechanisms would require an equivalent of base in
the RDS to remove the exchanging proton (to find it was base inhibited was quite
a conundrum). In opposition to Simchen’s results, addition of triethylamine was
found to increase the rate of H-D exchange for 23, which fits with the deprotonation
required in the RDS [Figure 2.5, Table 2.3]. This is discussed in further detail in
Section 2.2.3.
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Figure 2.5 Effect of NEt3 on H-D exchange
Table 2.3 Analysis of effect of NEt3 on H-D exchange
Components Parameter Value
23 Rate -0.00266
R2 0.92749
23 & Rate -0.00315
NEt3 R
2 0.98538
Given that the exchange is dependent only on a solvent with exchangeable deuterons,
deuterium oxide was assayed. Performing kinetic studies in deuterium oxide re-
sulted in an increased rate of H-D exchange, an approximately one-fold increase
over methanol-d4 [Figure 2.6, Table 2.4]. There are many potential reasons for this.
Deuterium oxide would be better able to stabilise the cationic species in a carbene
mechanism that feeds into the RDS, aiding the exchange. The hydroxide ion is also
less nucleophilic than methoxide, hence there would be less attack upon the cation
and resultant sequestration of the exchanging-species in other forms. Finally, for fis-
cal purposes, it was decided to complete the remaining kinetic studies in deuterium
oxide.
Kinetic studies on 23 were halted, however, when a new model became available for
use. It is prudent to point out that model compounds are synthesised and studied
to make systems simpler and therefore easier to approach. However, in this case
removing the tetraprenyl tail led to more difficulties because of the problem of
20
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Figure 2.6 H-D exchange of 23 in different solvents
Table 2.4 Half-life of H-D exchange in different solvents
Solvent Half-life (h)
CD3OD 28.2
D2O 12.0
polarity, and therefore subsequent purification. As a result, it could be asked why
the model was not altered to solve this. Towards this, methods were explored to
attach simple alkyl tails to substituted imidazole rings, with some success. However,
this work was ceased with the completed synthesis and observed H-D exchange of a
benzene-based model.
2.2 Benzene-based models
2.2.1 Synthesis of benzene-based models
It seemed prudent to investigate other models of malonganenone B, to test the
versatility of this exchange. N -methyl-2-(N -methylformamido)benzamide, 28, was
proposed that features a benzene ring in place of an imidazole ring. This model
was expected to benefit from a decreased dipole across the ring and less nitrogen
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atoms, enabling easier purification than for 23. Also, the presence of more bound
hydrogens would make spectroscopic analysis of any generated products easier. The
bond angles of a benzene ring, however, differ from those of the imidazole ring, and
there was a risk that this would make formation of the cyclic species necessary for
H-D exchange unfavourable.
Synthesis of this model, as before, was not straight forward. Initially synthesis
was attempted from N -methylanthranilic acid (29), which was converted to the
chloroanhydride with thionyl chloride then reacted with methylamine to try and
yield the compound 30 [Scheme 2.3.a].32 Given that a reactive electrophile is being
generated in a molecule with an amine, hence the chance for polymerisation, it is
not surprising this reaction was unsuccessful. An alternative method started with
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◦C, 1 hr, 98 %.
Scheme 2.3 Synthetic routes to 28
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dimethylation of benzoylene urea (31) by methyl iodide and potassium carbonate to
form 32 [Scheme 2.3.b].33 This was then ring-opened under the same conditions and
mechanism as per 23 to yield 30, but with the advantage that purification could be
achieved by a simple liquid-liquid partition. This was then formylated with mixed
formic acetic anhydride and purified by flash chromatography to give 28 as a white
crystal in good yield.
As with 23, it turned out a shorter synthesis to 28 had already been completed.
N -methylisatoic anhydride (33) is attacked by methylamine at the carbonyl closest
to the ring, which is less resonance stabilised than the other carbonyl and hence
is more electrophilic [Scheme 2.3.c].34 This generates the desired methylamine and
a carbamate that decarboxylates as per the synthesis of 23 to give the free amine
in good yield. Given the formylation methodology developed in this research was
better than that reported in the paper, this methodology was applied to complete
the synthesis of 28 in good yield. It seems prudent to comment that not all old
chemistry shows up in new databases.
2.2.2 Rotamers and cyclic species
Testing for H-D exchange in this model resulted in the observation of a new species.
Incubation of 28 in methanol-d4 did result in disappearance of the formyl resonance
with time, but all the other peaks of the molecule also disappeared with a new set
of resonances appearing [Figure 2.8]. Characterising this species by 2D NMR exper-
iments revealed that protons of both methyl groups exhibited HMBC correlations
to a carbon signal at 96.9 ppm [Figure 2.9]. Given that these methyls cannot couple
to the same carbon through the existing backbone, this suggested that a cyclisa-
tion event had occurred. MS of this species was unsuccessful, with only 28 being
observed. Given that all of 28 had been consumed as observed by NMR, it was
proposed that this new species was unstable and reverted to 28 under atmospheric
conditions. With the evidence available, a putative structure of 34 was proposed,
with uncertainty over whether the oxygen-bound substituent at the aminal ester
centre was OCD3 or simply OD.
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Figure 2.7 Cyclic species of 28, with key HMBC correlations shown
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For more conclusive evidence, the protonated form was synthesised. Compound 28
was incubated in methanol for a period of days, quickly concentrated and transferred
to chloroform-d to avoid hydrolysis or lose the putative methoxy adduct. As before,
MS only revealed the presence of 28. NMR spectroscopy, however, revealed a set
of resonances akin to those found for 34, with the notable addition of a resonance
integrating for a single proton at 5.77 ppm and a resonance integrating for three
protons at 2.93 ppm. HSQC correlations demonstrated that the proton with the
resonance at 5.77 ppm was attached to a carbon at 96.8 ppm, as for 34, whereas
the resonance at 2.93 ppm is attached to a carbon at 49.3 ppm, which is expected
for a methoxy group. As before, protons of both of the nitrogen-bound methyl
groups showed HMBC correlations to the ’cyclic’ carbon, in addition to the new
methyl protons showing correlations to this too. Reciprocated correlations were
seen between the proton at the ’cyclic’ center and the three methyl carbons. These
correlations provide good evidence towards this species having the structure 35.
Having proposed a structure for this new species, the mechanism of formation was
addressed. The cyclisation event is believed to occur according to the mechanism
presented earlier, with the amide nitrogen attacking the formyl carbonyl that, fol-
lowing proton transfer, generates aminal ester 36 [Scheme 2.4]. For the alkoxy
substituent to be able to bind to the exchanging center, the exisiting hydroxy group
must be removed. With the aid of the lone pairs of the two neighbouring nitrogens,
hydroxide, or water, could be ejected, generating the charged species 41. Due to
the delocalisation of the charge across both nitrogens, this species is expected to
be relatively stable. Nucleophilic attack from the solvent could then generate the
desired cyclic species, 34 or 35.
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Scheme 2.4 Proposed mechanism of formation of 34 and 35
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This mechanism is not without precedent and had been confirmed previously. Much
work has been done investigating the hydrolysis of amidines.35,36 In this mechanism,
an amidine, 37, accepts the addition of water at the amidine center to form a
hemiaminal ester, 38, followed by cleavage to yield a formamide (39) and an amine
(40) [Scheme 2.5]. Inspection of this mechanism reveals that this is the opposite
sequence of events as occurs in the formation of the cyclic species of 28, which,
given each step is an equilibrium, are applicable in directions. Studies have shown
this mechanism is base catalysed and, if the concentration of base is sufficient,
cleavage to 30 can be seen. Although this represents the opposite mechanism to that
presented, each reaction is an equilibrium and hence the mechanism is valid in both
directions. Studies investigating the mechanism of bromination of quinazolinone,
in which the perchlorate salt of 41 was studied, found this hydrolysis using the
exact compounds being studied in this thesis.37 Subsequently work was done to
demonstrate a tetrahedral intermediate in this hydrolysis reaction.38 Kinetics for
each equilibrium in this reaction were analysed using UV and NMR spectroscopy
and the mechanism they propose matches that proposed here.
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Scheme 2.5 Mechanism of hydrolysis of amidines
Discovery of this cyclisation and deduction of the mechanism of formation also
helped explain the rotamers. Characterisation of each rotamer shows that they are
constitutionally identical, with the same bond connectivity, and were believed to
differ only in their conformation in space. Given the steric size of each group and
their proximity to the benzene ring, it can be concluded that both substituents
cannot be planar with the ring at the same time. Instead, each substituent must
be twisted out of the plane and, depending on the orientation, different rotameric
species can be formed [Figure 2.10]. The change in ratio in different solvents was
puzzling, however, until now: interchange between rotamers is possible, but only
through the tetrahedral intermediate 36, which can open to yield either rotamer.38
Although bond breaking is required to interchange these, and hence they could be
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Figure 2.10 Possible distributions of the substituents of 28 in space
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argued as configurational isomers, they only differ in rotation about a single bond,
which is impeded in this system, hence the “rotamer” nomenclature is valid.
These cyclic species are the first conclusive evidence towards explaining the H-D
exchange of malonganenone B. Although the work on amidines has only previously
been completed on benzene-based compounds, the same mechanisms can be applied
to the imidazole-based systems. The absence of demonstration of an aminal ester
for 23 is believed to be due to the cyclic species being less stable. In 28, cyclisation
involves formation of two fused 6-membered rings, which is a wellknown stable
system. In 23 however, a fused-5,6-bicyclic system is formed. The geometry of the
bridge-head carbons is different in the 5-membered ring, with the substituents being
angled further from each other. Formation of the 6-membered ring is likely further
hampered by the appearance of an amine and a lactam moiety in the ring, and
the possible effect of the lone pair on the nitrogen of the imidazole ring. Although
these effects may be only subtle changes in geometry and structure, the effect on
population sizes in the equilibrium system could be quite pronounced. Nonetheless,
these results suggest that cyclisation is occurring in our system to generate aminal
esters, hence the mechanisms proposed by Simchen are applicable here. Further,
the implication of the cationic species 41 is very good evidence towards the carbene
mechanism being in operation.
2.2.3 Kinetic studies of 28
Amongst the discovery of the new cyclic species forming, the successful demonstra-
tion of H-D exchange in another model was overlooked. As noted earlier, there was
no equivalent resonance in the species 34 for what was the formyl proton. As has
been confirmed by further studies, this is indeed due to H-D exchange occurring with
this proton. In methanol-d4, the half-life of the exchange is 13.5 hours as opposed to
28.3 hours when compared to 23, meaning the exchange occurs at more than double
the rate [Figure 2.11, Table 2.5]. When trialling the exchange in deuterium oxide,
the formyl resonance was lost but the other peaks remained the same- the hemiami-
nal ester is obviously not as stable as the aminal ester [Figure 2.12]. Comparing the
Table 2.5 Half-life of H-D exchange of different models in different solvents
Species Solvent Half-life (h) R2
23 CD3OD 28.3 0.999
D2O 12.0 0.999
28 CD3OD 13.5 0.988
D2O 1.5 0.999
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Figure 2.11 H-D exchange of different models in different solvents
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rate of exchange in deuterium oxide instead, 28 has a half-life that is 8-times shorter
than for 23, 1.5 and 12 hours respectively. The argument previously supporting the
observation of cyclic species for 28 but not for 23 can be applied here. As a result
the intermediates and transition states required for the H-D exchange of 28 are more
stable and there is less of an energy barrier for molecules to exchange. This idea of
stable species can be developed further by the observation that 28 reacts 9-times
faster in deuterium oxide than methanol-d4. It can now be argued that the cyclic
species 34 is actually too stable and sequesters some of the exchanging population,
meaning that less progresses though the steps of the exchange with methanol-d4
as the solvent compared to deuterium oxide, ergo the rate in the former solvent is
slower. Effects of increased polarity of solvent better stabilising the charged inter-
mediates and the decreased nucleophilicity of hydroxide compared to methoxide also
likely influence this.
Before full kinetic studies were completed, the effect of source and analysis method
were assessed. Given the difficulties associated with purity of different sources of 23,
the half-life of exchange for each source crystal was assessed before use. Whereas
large differences were seen for 23, the rate of exchange for 28 is largely independent
of source [Figure 2.13]. This is a reflection of the better separation and purification
that is possible with 28 due to its lower polarity compared to 23. The benefit of
a shorter life-time for the exchange is that the Half-Life method can be used for
analysing the rate. Mapping this data over multiple half-lifes gives high accuracy,
as compared to approximating a linear model to the start of an exponential curve for
the Initial Rate method. Unfortunately, the data could not be collected over multiple
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half-lifes in all cases, due to some long half-lives of the exchange, and hence some
of the experiments have less accurate estimates. The other advantage of this model
is that it has a shorter relaxation time of the resonances in the molecule meaning
that more data can be acquired in a shorter time, allowing for more accurate data.
Given the choice of methanol-d4, in which the disappearance of the two rotamers and
appearance of the aminal ester need to be assessed for each spectrum, or deuterium
oxide, which is less expensive and involves only following the loss of two peaks
relative to two sets that are unchanging, remaining kinetic studies were performed
in the later solvent.
The effect of concentration of 28 on the rate of H-D exchange was investigated but
with limited success. The half-life of exchange at different concentrations of 28 were
assayed [Figure 2.14, Table 2.6]. R2 values have been omitted from the table as
all fits had a value of 0.999. There appeared to be a good relationship between
concentration and half-life, but this was complicated by some of the studies that
were performed at a later date; the only difference that can be imagined would be
in the absorbance of water from the atmosphere or decomposition of the sample.
Logarithms of the half-life and concentration were plotted against each other and
a linear model applied, which, according to Equation 1.15, would have a gradient
equal to one minus the order of the species [Figure 2.15]. Although this gradient
suggests it is closest to first order, given the low fit of this data (R2 = 0.777) no
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Figure 2.14 Concentration-dependence of H-D exchange of 28
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Table 2.6 Half-life of H-D exchange of 28 at different concentrations
Concentration Half-life
(mmol/L) (min)
37.8 134.9
56.8 148.7
75.7 99.4
94.6 98.9
113.5 88.9
170.3 79.7
1 . 5 1 . 6 1 . 7 1 . 8 1 . 9 2 . 0 2 . 1 2 . 2 2 . 3
1 . 9 0
1 . 9 5
2 . 0 0
2 . 0 5
2 . 1 0
2 . 1 5
2 . 2 0
log(
t 1/2)
l o g ( C o n c e n t r a t i o n )
l o g ( t 1 / 2 )  =  - 0 . 4 2 . l o g ( [ 2 8 ] )  +  2 . 8 2
R 2  =  0 . 7 7 7
Figure 2.15 log(t1/2)-dependence on log(concentration) of 28
conclusions could be drawn with confidence [Figure 2.15]. Given the number of steps
from this analyte to the RDS, it is not surprising that this data is not useful.
As previously, results with regards to acid and base are contrary to those reported
by Simchen. Addition of triethylamine resulted in an acceleration of the H-D ex-
change, as for 23, but addition of acetic acid-d4 acted to completely inhibit the
exchange [Figure 2.16]. Although Simchen originally had problems reconciling his
observations, these findings support the possibility of either the ylide or carbene
mechanism; both involve deprotonation in the RDS, which exogenous base would
aid whilst exogenous acid would inhibit. Exploring this with other bases, namely
sodium hydroxide and dimethylaminopyridine, showed similar catalytic activity. In-
vestigating the response of the rate to the concentration of base would allow an
exploration of this catalysis.
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Figure 2.16 Effect of acid and base on rate of H-D exchange of 28
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Figure 2.17 Effect of different concentrations of NEt3 on rate of H-D exchange
of 28
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The effect of concentration of triethylamine on the rate of H-D exchange was investi-
gated but also met with limited success. Triethylamine was chosen for concentration
studies as it is a stable, non-nucleophilic base, avoiding concerns about side-reactions
occurring. Varying the concentration from 56.6 mmol/L, 1 stoichiometric equivalent,
to 215.1 mmol/L, 4 equivalents, showed absolutely no change in rate between the
different concentrations, such that there was no point in analysing this data further
[Figure 2.17]. Although this could be taken as the reaction being independent of
the concentration of base, these rates are still faster than 28 alone. The conclusion
drawn therefore is simply that the rate is independent of [triethylamine] at these
concentrations of base. This suggests that the maximal rate of catalysis has been
achieved and that the reaction simply can not go any faster. The solution to this is
to assay the rate of reaction at substantially lower concentrations, which, since the
base is not the analyte and hence needs not be at a concentration that is observable
by NMR spectroscopy, is achievable in this experimental setup, as shown in Section
2.3.2.
Kinetic studies on this benzene-based model have progressed the level of knowledge
towards solving the question of the mechanism of H-D exchange of malonganenone
B. The main advantage this model has over 23 is the ability for it to be suitably
purified, using flash chromatography. Demonstration of a cyclic species is important
to the cause in that it allows Simchen’s mechanisms, which admittedly are the only
that have been proposed to date, to be applied to our system. Although kinetic
studies assessing the order of the exchange with respect to 28 were unsuccessful,
it has demonstrated that the exchange responds in opposition to acid and base as
how Simchen originally reported. The major failing point of this model is that it is
too many steps from the RDS, such that useful kinetic data may not be obtainable
from this system. With the help of a serrendipitous discovery, however, this problem
could be overcome.
2.3 Quinazolinium-based models
2.3.1 Synthesis of cationic species
Attempts to trap a cyclic species had a very serendipitous outcome. To demon-
strate the existence of an aminal ester resulting from formation of the second ring
during H-D exchange in 28, an attempt was made to trap the resulting oxyanion
covalently with compounds that had very labile leaving groups. It was expected
that the cyclisation would occur in most solvents, so experiments were run with a
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Scheme 2.6 Attempts to trap a cyclic intermediate involved in the H-D exchange
mechanism
sulfur trioxide-pyridine complex in DMF39,40 and also in neat ethylchloroformate,
to try and form the sulfate (42) and carbonate (43) respectively [Scheme 2.6].41,42
Nothing formed in the sulfur reaction, but something new appeared in the reaction
with ethylchloroformate that was not the expected product; instead it was found to
be the cationic species 1,3-dimethyl-4-oxo-3,4-dihydroquinazolin-1-ium chloride, 41.
Upon cyclisation, the generated oxyanion was expected to attack the carbonyl of the
ethylchloroformate with loss of a chloride leaving group to generate 44 [Scheme 2.7].
Instead of this species being stable as expected, it is believed the lone pair of one of
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34
the flanking nitrogens could donate to the exchanging-centre, with ejection of carbon
dioxide and ethanol, generating the cationic species 41 as the chloride salt. In hind-
sight, with the expulsion of an equivalent of gas it is not surprising the intermediate
species 44 was not stable.
This species became of exceptional importance to this research. The existence of
this compound in itself is very strong evidence towards the carbene mechanism.
Given that this species represents the input molecule for the RDS for the proposed
carbene H-D exchange mechanism, the possibility for obtaining useful kinetic data
towards the order of the mechanism was possible. The other important role of this
molecule is that it represents a carbene precursor as used in synthetic studies to
generate N-heterocyclic carbenes, which is addressed in Chapter 3.
In addition to synthesis using ethylchloroformate, other methods were explored.
One of these involved starting from 4-hydroxyquinazolinone (45), which was heated
in a pressure tube with methyl iodide and an equivalent of sodium bicarbonate
[Scheme 2.8].43 This resulted in addition of a methyl group to each of the nitro-
gens to generate the desired product as the iodide salt. Unfortunately, purification
of this from the mono-alkylation product and remaining sodium bicarbonate was
unsuccessful. An alternative method involves using the precursor to 28, 30, and
DMFDMA. In this both nitrogens attack the DMFDMA, with loss of good leaving
groups, followed by loss of the final heteroalkane to generate the desired product.
Although this is a typical method to generate N-heterocyclic carbenes, it was un-
successful here as the amide moiety was not sufficiently nucleophilic to complete the
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35
cyclisation of 46. The ethylchloroformate method was used for all further studies.
In this, there is a risk that if any ethylchloroformate has hydrolysed, hydrochloric
acid would remain, as the only nonvolatile byproduct of this reaction, which would
act to completely inhibit any H-D exchange, as was seen with one sample of 41.
As a result, all sets of studies were performed on the same source of 41 to avoid
impurity issues.
Attempts were made to obtain the imidazole-based cation 47 but this was unsuc-
cessful. Synthesis from the precursor 27 with DMFDMA was unsuccessful, despite
the beauty of the reaction with all reagents and solvents distilled off to drive the
equilibria to completion [Scheme 2.9]. As opposed to the benzene-based model, the
cyclisation occurred to form the second ring, with the intermediate 48 being iso-
lated. Upon treatment with methanolic formic acid, this appeared to form 47, with
a resonance above 11 ppm in the 1H-NMR spectrum, but this quickly degraded.
Ethylchloroformate was also trialled with apparent success: a similar compound
with a peak above 11 ppm in the 1H-NMR spectrum was observed. However, this
was not synthesised in high enough yield and was not easily purified. Further, the
species again proved to be highly labile and readily hydrolysed. For these reasons,
kinetic studies were limited to the benzene-based cation 41.
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2.3.2 Kinetic studies of 41
Although it was believed that 41 would be too susceptible to hydrolysis for use in
kinetic studies, initial observations were good. In the beginning, there was much
hesitation in removing this compound from an inert atmosphere, let alone dissolving
it in deuterium oxide. However, 41 showed surprising stability to both atmospheric
conditions, where no hydrolysis was seen over a time period of weeks, and aqueous
conditions, where no hydrolysis was seen in the timescale of the H-D exchange.
Basifying deuterium oxide with potassium carbonate was able to exact the hydrolysis
in a shorter timeframe to confirm hydrolysis to 49 [Scheme 2.10]. Meanwhile, H-D
36
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Scheme 2.10 H-D exchange of 41
exchange of the amidine proton to 50 was occurring smoothly, as seen by the decrease
in the amidine resonance, at approximately 9.5 ppm, with time in deuterium oxide
[Figure 2.18].
41 was found to undergo H-D exchange faster than for 28 with the same response
to exogenous acid and base. The half-life of the H-D exchange in 41 was found to
be shorter than that for 28, 80 minutes as compared to 149 minutes [Figure 2.19,
Table 2.7]. This is not surprising, given that this is the immediate starting material
for the RDS, whereas 28 is a number of mechanistic steps away. This means that
the majority of the population is closer to the RDS and it is a shorter time for
molecules to reach the transition state. However, 41 did respond similarly to 28
with regards to acid and base: addition of acetic acid-d4 led to a complete inhibition
of exchange, whereas triethylamine promoted this [Figure 2.20, Table 2.8]. Although
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Figure 2.18 1H NMR spectra of 41 with time in D2O
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Figure 2.19 H-D exchange of 28 and 41
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Figure 2.20 Effect of acid and base on the rate of H-D exchange of 41
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Table 2.7 Half-life of H-D exchange of 28 and 41
Species Half-life (min) R2
28 148.7 0.999
41 80.0 0.999
Table 2.8 Effect of acid and base on the half-life of the H-D exchange of 41
Additive Half-life (min) R2
No additive 21.4 0.998
NEt3 12.5 0.996
CD3COOD - -
further [acid] studies could have been performed, the data obtained would not allow
much insight into the mechanism of exchange as the RDS dominates the observed
rate law. Observation of acid inhibition is sufficient for these studies.
The correlation found between the concentration of 41 and half-life was unexpected,
but suggestions can be made towards its origin. Although it would be expected that
the rate would increase with an increase in concentration, assaying the H-D exchange
at different concentrations of 41 showed the opposite: the lowest concentrations of
41 exchanged the fastest [Figure 2.21, Table 2.9]. This could be rationalised in
that 41 is inherently acidic: in formation of the carbene an equivalent of H+ is
liberated. At higher concentrations of 41, the population of carbene, and hence
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Figure 2.21 Half-life of H-D exchange with respect to concentration of 41
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Table 2.9 Effect of concentration of 41 on half-life of H-D exchange
Concentration (mmol/L) Half-life (min) R2
8.7 12.7 0.997
18.2 21.4 0.998
26.0 25.7 0.999
34.6 30.0 0.995
H+, is higher and could become self-inhibitory. However, the larger population of
carbenes would suggest a higher rate of exchange. A more reasonable rationale is
due to residual hydrochloric acid on the surface of the analyte. As more analyte
was used, more acid was introduced to the system and the increased acidity would
increasingly inhibit the exchange. A solution would be to purify the analyte further,
which is problematic, or assay at lower concentrations where this is less significant.
Herein lies the problem with using NMR spectroscopy to follow the kinetics: only
a narrow concentration range of the analyte observed can be tolerated. There are
difficulties shimming the instrument at high concentrations and at low concentra-
tions it can not accurately observe the signals of the material due to the insensitivity
of the technique. Whereas a concentration range of 104,000-fold was possible with
triethylamine, which need not be observed, only a 4-fold difference was possible with
41. A different spectroscopic technique, or a revision of the existing method, would
be required to investigate this further.
Kinetic studies investigating the effect of [triethylamine] were not similarly lim-
ited, but finding the necessary concentrations to test took much experimentation.
For these base-concentration studies, the dissociation of deuterium oxide was ig-
nored; even at the lowest concentration of triethylamine used, the concentration of
exogenous base was more than 100 times that of the dissociation of water, so its
contribution was assumed to be negligible. A correlation was observed that increas-
ing the concentration of base increased the rate of exchange, as would be expected
for a base-catalysed model. Indeed the highest concentration of base, 1042 mmol/L,
resulted in an exchange that was too fast to be accurately monitored [Table 2.10,
Table 2.10 Initial studies into the effect of concentration of NEt3 on half-life of
H-D exchange of 41
Concentration (mmol/L) Half-life (min) R2
1042 - -
1.055 6.3 0.997
0.844 5.7 0.997
0.633 9.0 0.999
0.422 8.3 0.999
0.211 12.5 0.996
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Figure 2.22 Initial studies into the effect of concentration of NEt3 on rate of H-D
exchange of 41
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Figure 2.23 log(t1/2)-dependence on log(concentration) of NEt3
41
Figure 2.22]. Plotting the logarithms of the concentration and half-life against each
other gave a linear trend with a gradient of -0.44, which corresponds to an order
of 1.44 for base in the RDS [Figure 2.23]. The data was not ideal, as can be seen
visually and as shown by the R2 value of 0.78. More data was needed to be collected
to supplement this data set, but due to the requirement of only comparing kinetic
experiments run from the same sample, these had to constitute an independent
set of data. Also, to allay fears that the concentrations used were approaching a
rate-saturation point, much lower concentrations were assayed using dilute standard
solutions.
The second study into the effect of base on the H-D exchange justified the need to
continually assay lower concentrations. The constant fear that the concentrations
investigated were approaching the maximal rate of exchange, and hence displaying a
non-linear response between concentration and rate, was warranted when visualising
the half-life against the concentration [Figure 2.24, Figure 2.25]. It is apparent that
these values describe an exponential curve, with higher concentrations resulting in
a half-life that is approaching a minimum value, the maximum rate of exchange,
which is approximately 0.5 minute. Having started the first base study with a
concentration 1043 mmol/L, this justified the need to go down to a concentration
of 0.01 mmol/L, a 104,300-fold decrease in concentration.
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Figure 2.24 Final studies into the effect of concentration of NEt3 on half-life of
H-D exchange of 41
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Figure 2.25 Half-life of exchange of 41 with changes in [NEt3]
The kinetic studies with the lowest concentrations of base gave good evidence to-
wards the order of base in the RDS. Analysing the lowest five sets of data, by
plotting the log of t1/2 against log(concentration), resulted in a linear model with
a gradient of -0.060 and an R2 value of 0.812 [Figure 2.26]. The fit of the model
could be better, but it is apparent one of the data values is slightly erroneous, which,
given the concentrations being used, is understandable. Nonetheless, a gradient of
-0.060, or approximately 0, means the exchange is, according to Equation 1.15, first
order with respect to base. This disproves the self-protonation mechanism, as this
would be zero order with respect to base, whilst supporting both the carbene and
ylide mechanisms. However, given how close this estimate is to the ideal value for
a first order reaction, there is more support for the carbene mechanism over the
ylide. From 41 the exchange, according to a carbene mechanism, is one step and
first order with respect to base, as these findings suggest. The ylide mechanism,
however, involves an additional protonation step that would be disfavoured under
basic conditions and should make the observed rate law deviate from an exact first-
order value. Given the accuracy of the estimate for the order, the exchange would
appear to go through a carbene mechanism.
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Figure 2.26 log(t1/2)-dependence on log([NEt3]) at low concentrations
2.3.3 Kinetic studies of DMFDMA
To address the contradiction of this data with Simchen’s observations, studies on
DMFDMA were attempted. Simchen originally found acid catalysis and base in-
hibition of H-D exchange, but he had difficulty reconciling this with his mecha-
nisms. To attempt to confirm this independently, kinetic studies were performed on
DMFDMA. Simchen’s original studies were composed of reacting this species neat
in a 1:1 stoichiometric ratio with deuterated solvents. Instead of following their
original method, it was instead decided to attempt kinetic studies using dilute solu-
tions as have been performed throughout this research. Kinetic studies were run in
different solvents and the response to different concentrations of the analyte, as well
as changes in concentration of exogenous acid and base were analysed [Figure 2.27].
There appeared to be no effect on the rate of H-D exchange due to the presence or
absence of acid or base, which seemed to go against all results to date.
There are certain inherent difficulties in studying DMFDMA, however. Deuterated
DMFDMA (51) was observed by NMR and MS, confirming exchange occurred.
However, DMFDMA is in itself the solvent adduct (methanol) of a solvent (DMF,
52), which makes following the resonances in NMR spectroscopy, where peaks from
residual, non-deuterated solvents are typically ignored but nonetheless present, dif-
ficult. As seen in a study in deuterium oxide, DMFDMA (15) hydrolysed back to
44
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Figure 2.27 H-D exchange of DMFDMA under varied conditions
these base solvents, with some deuterated DMF (53) observed. Alternatively, in
other solvents, such as methanol-d4, it can exchange groups for their isotopically-
labelled, and NMR-invisible, counterparts (54). Given that a deuterated-solvent
is required, this is unavoidable. But to monitor the exchange of the amide acetal
proton for a deuteron requires comparison to an existing, unchanging peak. Due to
ligand exchange, this is limited to the dimethylamine substituent. However, evidence
of the iminium compound 55 was observed by MS, suggesting that there is ligand
exchange of the dimethylamine substituent as well. Needless to say, with every part
of the molecule changing or exchanging, bar the central carbon, kinetic studies on
this species are challenging and outside of the scope of this research. Simchen’s
findings of acid catalysis and base inhibition in the H-D exchange of DMFDMA
remain to be confirmed.
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Figure 2.28 Species appearing in the DMFDMA kinetic studies
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Chapter 3
Trapping a carbene
The research now shifted from trying to understand the H-D exchange phenomenon
to trying to prove the mechanism. Although this was a risky gamble, in that if
nothing works nothing is learned, it was believed to be known which mechanism was
occurring and sought to prove this. The body of evidence from this research, as well
as literature work on carbenes and NHCs, led us to believe a carbene was generated
in the H-D exchange of malonganenone B. The best evidence for this therefore
would be to trap a carbene. The ideal starting point was akin to how carbenes
were first demonstrated; by reaction with an alkene to generate a cyclopropane.15,44
Carbenes, as divalent, neutrally-charged carbon species, also have a tendency to
dimerise to form fulvalenes, which can undergo further reactions to generate more
stable species.45,46 Finally, NHCs have had their most important work as ligands in
organometallic complexes.16,21,22 Given that the carbene proposed here is similar to
existing NHCs, albeit a new class that has never been reported, following existing
methods to generate an organometallic species was the final approach to be explored.
3.1 As a cyclopropane
3.1.1 Intermolecular attempts
Attempts were made to trap the model compounds available with exogenous alkenes.
NHCs are highly nucleophilic carbenes, due to the electron-donating properties of
the two adjacent nitrogen atoms. With the carbene proposed here, this effect would
be lessened by the fact one of the nitrogens is part of an amide, which would draw
46
electron density to the carbonyl rather than the carbene. For this reason it would be
expected that these carbenes are nucleophilic, but not to the same extent as existing
NHCs. As for many chemical reactions, it is important to match the energies of the
reagents; in this case, matching the LUMO of an alkene with the high HOMO
of the carbene. Towards this end, alkenes with electron-withdrawing groups were
investigated to a greater degree. A wide range of alkenes was trialled, however,
limited only by what was available.
Initially attempts were made to trap the imidazole-based carbene 56 but these were
unsuccessful. 10 equivalents of allyl alcohol or cyclopentene were added to a solution
of 23 in methanol in an attempt to form 57 and 58 respectively, but these were
unsuccessful [Scheme 3.1].47 It was hoped that in the dynamic equilibria of the H-D
exchange, a trapping event may occur. But, given the number of steps required to
reach the carbene and the proposed short half-life of this species, particularly in a
nucleophilic solvent, the chance of such an event occurring is very low and it is not
surprising that no trapping was observed.
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Scheme 3.1 Attempts to trap 47
Similar attempts were made to trap the carbene resulting from DMFDMA, 59, and
the benzene-based carbene 60 with revised reaction conditions and reagents. To
try and prolong the half-life of the carbene, non-nucleophilic solvents were trialled,
namely tetrahydrofuran and dichloromethane. It was expected that the largely in-
tramolecular reactions, and hence carbene formation, would still be occurring in
these solvents and that leaving the reactions for a prolonged period would increase
the probability of a trapping event occurring. To try and match the energy levels
of the orbitals, alkenes with electron-withdrawing groups were required: diethy-
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lacetylenedicarbonate, tetracyanoethylene and hept-2-en-1-al were trialled in the
reactions. Unfortunately, attempts to synthesise 61 to 66 were unsuccessful, even
after leaving for three months to react [Scheme 3.2, Scheme 3.3].48,49 60 was also
attempted to be trapped with 2-hexenal and cyclopentadiene to form 67 and 68
respectively,48,50 but this met with the same glorious outcome. Reactions were also
performed in neat diethylacetylenedicarbonate, but this was similarly unsuccess-
ful. There is a possibility that these solvents were too nonpolar and generation of
the charged carbene precursor was disfavoured, inhibiting carbene formation. This
represents something of a Catch-22, in that polar solvents may be necessary for
formation of the carbene, but these simultaneously decrease its half-life.
Given the number of steps from these models to the carbene, trapping reactions
were performed instead on 41 using known carbene-generating methods. In this
set of reactions, a base, such as sodium hydride, exacts abstraction of the proton to
generate the carbene directly and nonpolar solvents, such as tetrahydrofuran, can be
used to solubilise the generated carbene, extending its lifetime and making a trapping
event more likely. Using 41, generated previously or in situ, in tetrahydrofuran or
dichloromethane, degassed or as was, with sodium hydride or triethylamine for base,
a number of trapping reactions were trialled. Renewed attempts to form 64 and 65
were unsuccessful [Scheme 3.4], although the later generated an exciting crimson-
red colour which resulted from a single-electron transfer between triethylamine and
tetracyanoethylene.51 Triethylamine was only trialled over concerns that the sodium
hydride available was partially hydrolysed, which is discussed later along with the
need for the degassing of solvents. To assay a range of alkenes with different energies,
styrene,52 methyl acrylate,53 ethyl vinyl ether54 and ethyl maleate55 were used to
try and synthesise 69, 70, 71 and 72 respectively. The outcome of these reactions
was a mixture of 28, hydrolysed starting material, and 32, one of the intermediates
in the synthesis of 28 but which also represents the oxidative degradation product
of a dimerised carbene species. The formation, and importance, of this species is
covered later. In summary, all intermolecular trapping events with alkenes were
unsuccessful.
3.1.2 Intramolecular attempts
Intramolecularly-bonded alkenes were next to be trialled. It was expected that
tethering the alkene, making it an intramolecular reaction, would boost the chances
of a trapping event occurring. The tethered-alkene compounds 73 and 74 were
intended to be synthesised, which were expected to lead to the cyclopropanes 75
and 76 respectively. Although the energy levels of the carbene and alkene are
49
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Scheme 3.4 Attempts to trap 60 generated from 41
not well matched, it was believed the increased proximity would overcome this.
These compounds could be easily obtained using the methodology developed in
this research by changing the amine used in the ring-opening of N -methylisatoic
anhydride.
Although 73 was successfully synthesised, no trapping occurred. Pent-4-en-1-amine
(77) was synthesised from the corresponding bromide in methanolic ammonia and
equilibrated in a bicarbonate solution to give the free amine 77 [Scheme 3.5].56
This was then reacted with N -methylisatoic anhydride to give the precursor com-
pound 78, which was formylated to give the pentene derivative, 73. After leaving
this to exchange, and therefore hopefully to cyclopropanate, in the polar solvent
dimethylsulfoxide-d6 for seven days, no change was observed by NMR spectroscopy.
When this was repeated in methanol-d4, the product underwent solvolysis, with no
trapping occurring.
Even though the cationic species 80 was obtained, no trapping was observed. As
before, 81 was synthesised from the equivalent bromide but left as the ammonium
bromide salt to avoid loss of material [Scheme 3.6]. This was then reacted with
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N -methylisatoic anhydride to form 82 and formylated to give 74. Incubation in
methanol-d4 led to the methanol-adduct 79 forming, which highlights that 74 is
chemically similar to the methylated parent compound, hence it is expected that
carbene-formation would be occurring. Using the methodology available from the
work with 41, this was converted into the cationic species 80 using ethylchlorofor-
mate. This allowed the carbene to be generated directly and hence increase the
chance of trapping. However, reacting this species with triethylamine in degassed
chloroform-d gave only the hydrolysed product 74. As was prewarned in the preface
of this section, if nothing worked, as occurred here, nothing was learnt about the
H-D exchange, except for ways to not demonstrate the existence of a carbene.
3.2 As a dimer
The ability of carbenes to dimerise was utilised in the next approach towards proving
the existance of a carbene in this exchange. Given the successful attainment of 41,
the synthesis of dimeric species 84 was attempted first. Treatment with sodium hy-
dride in tetrahydrofuran resulted in a set of peaks that, at this time, were believed to
belong to a previously unseen product in this project [Scheme 3.7]. Through NMR
and MS investigations it was found that this species was not 84 but the oxidative
degradation product of this, 32. It is well known that enetetramines undergo ox-
idative cleavage in the presence of oxygen, forming first the 1,2-dioxirane 85 from
a [2+2] cycloaddition with oxygen which then undergoes a pericyclic cleavage to
give the urea 32 [Scheme 3.8].57,58 After realising this structure, it was found that
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Scheme 3.8 Oxidative cleavage of 84 to give 32
the spectra of this perfectly matched those of one of the intermediates in the initial
synthesis of 28 [Scheme 2.3].
Although this is not a direct demonstration of a carbene, it is good indirect evi-
dence towards its existence. There are other possible mechanisms through which
the formation of 32 could have occurred, however, these usually require aggresive
reagents59,60 or reactive oxygen species.61 Given that these conditions were absent,
but that the leakage of air into the reaction was possible, this adds support to the
theory 32 formed as a result of degradation of 84. Given the lack of steric bulk
around what is an electron-rich, highly-reactive alkene, it is not surprising that the
compound decomposes, even if this, as an enediaminediamide, is less electron rich
and hence less reactive. Where 32 was observed in some of the previous trapping
studies, this is evidence that the carbene was formed, and that trapping, as opposed
to generation of the carbene, was unsuccessful. As a side thought, it is disappointing
that the equivalent carbene precursor could not be generated from 23, because it is
also known that the oxidative cleavage of enetetramines generates light.62 One can
only imagine the PR campaign possible if an energy drink were to contain the dimer
of this, which, when you opened the bottle, emitted light and synthesised caffeine!
Observation of this species was crucial in the drive towards using full Schlenk
conditions with the equipment available. A synthetic organic chemist’s and an
organometallicist’s concept of inert conditions are somewhat different; the former
would exclude air from the reaction itself but perform a work-up under atmosphere,
whereas the later would never let the compound come in contact with air. To try
and exclude oxygen, and hence cleavage of any dimer, the experimental techniques
and methods were continually improved to ensure inert conditions, measured by
the presence of 32. This culminated in reactions performed in NMR tubes under
argon with degassed solvents. Many unsuccessful reactions could have been avoided
if these conditions were employed at an earlier stage, but the learning process is an
integral part of any research.
Given the instability of 84, other dimers that rearrange to stable species were pro-
posed. With allylic or benzylic substituents, the dimer can undergo intramolecular
reactions. Allyl-substituted dimers, 86, undergo a [3,3]-sigmatropic amino-Claisen
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Scheme 3.9 Mechanisms of rearrangement of substituted dimers
reaction to form the stable species 87 [Scheme 3.9.a].45 It has been suggested, how-
ever, that this forms instead through a radical mechanism,46 which is the mode
of degradation for the tetrabenzyl species (88). In this, a benzyl radical sponta-
neously leaves generating the resonance-stabilised radical 89, which undergoes an
intramolecular radical reaction to eject a second benzyl radical and forms the stable
biamidine 90 [Scheme 3.9.b].63 Although the chemistry of our compounds is un-
doubtedly different, with the presence of an amide which could have serious effects
in a radical mechanism, synthesis of the allyl- and benzyl-substituted species was
attempted.
Although the dibenzyl compound 91 was synthesised, lack of purity defeated any
attempted use. An exceedingly efficient method to this compound is through the
reaction of 4-hydroxyquinazoline (92) with benzyl bromide in the presence of an
equivalent of sodium bicarbonate [Scheme 3.10].46 In this the two ring nitrogens at-
tack benzyl bromide leading to alkylation and generation of the carbene-precursor
cation 91, which was successfully obtained according to MS analysis. As one could
imagine, purifying a cationic salt, 91, from the unreacted starting-material salt,
sodium bicarbonate, and the ionic byproduct, sodium bromide, might pose difficul-
ties. It did. Despite multiple attempts to extract with organic solvents and flash
chromatography, sufficient purity of 93 was never obtained. By the end of the at-
tempted purification process, the major impurity was the hydrolytic degradation
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product of 91, the dibenzyl-equivalent of 28. Continuous liquid-liquid extraction
could be a possible way to purify this in the future, however this usually utilises
water as one of the solvents, which may not be ideal. Ion exchange chromatography
may be a way forward instead. Given the low purity of this compound, it was not
subjected to carbene-generating conditions.
Although the diallyl species was made and purified, formation of the dimeric species
was unsuccessful. As before, 4-hydroxyquinazoline was reacted with allyl bromide
to give the cation 94, which, given the knowledge garnered from the synthesis of
the benzyl derivative, was able to be sufficiently purified by repeated solvent ex-
traction [Scheme 3.11]. Subjecting this to standard carbene-generating conditions,
sodium hydride in degassed tetrahydrofuran, resulted in the hydrolytic product of
the starting material, 95. Repeating this experiment in an NMR tube under argon
with degassed chloroform-d and triethylamine resulted in the same product being
isolated. As was the case for the imidazole-based cation, this species was highly
susceptible to hydrolysis. Although all the dimeric trappings were unsuccessful, the
observation of 32 is good evidence towards the existence of a carbene.
3.3 With organometallic compounds
The final method used to demonstrate a carbene involved organometallic species,
which, fortunately, was more successful. As mentioned previously, NHCs are good
ligands in organometallic chemistry, ergo an attempt was made to demonstrate our
novel NHC through one such complex. The acetate anion of palladium acetate
has been found to be sufficient to induce deprotonation of NHC precursors, and
catalyse formation of organometallic species by itself.64,65 The first attempt to form
a palladium species relied upon the spontaneous, in situ generation of the carbene
in a range of solvents, which could then dimerise and suffer oxidative addition of
palladium into the alkene. Given the number of mechanistic steps involved in this,
this approach involved a certain level of optimism.
Attempts to trap a carbene in this way, despite being numerous, were unsuccessful.
DMFDMA and the imidazole- and benzene-based models from the kinetic studies
were incubated with palladium acetate in various solvents for a period of time in
the hope of observing the species 96, 97 and 98 respectively [Scheme 3.12]. No
new species were observed, except for the successful synthesis of palladium mirrors
on the inside of the vessels. Subjecting 41, after its in situ formation, to these
same conditions was similarly unsuccessful. Using 41 in a method that utilised
56
NN
O
N
H
N
O
H
N
NN
N
O
N
N N
N
O
Pd
ClCl
N
H
N
O
O
H
N
N
O
N
N
O
Pd
ClCl
ii
i
N O
O i O
N
O
N Pd
ClCl
N
H
N
O
O
H
N
N
O
N
N
O
Pd
ClCl
iii N
N
O
H
iv
N
N
O
H
N
N
O
N
N
O
Pd
ClCl
Cl
v, vi or vii
N
N
N
O
Pd
ClCl
viiiN
N
O
H
Cl
23 97
28
28
98
98
98
15
96
41
41
41
99
Reagents and Conditions: i. Pd(OAc)2, DCM OR THF, rt, 3 months; ii. Pd(OAc)2, CD3OD, rt,
7 d; iii. ethylchloroformate, 50 ◦C, 3 h; iv. Pd(OAc)2, NaH, THF, rt, 3 h; v. Pd(OAc)2, ’wet’
DMSO, rt, 12 h; vi. Pd(OAc)2, NaOAc, THF, rt, 12 h ; vii. Pd(OAc)2, degassed CDCl3, rt, 4 d;
viii. Pd(OAc)2, K2CO3, pyridine.
Scheme 3.12 Unsuccessful attempts to form palladium-carbene complexes
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’wet’ dimethylsulfoxide also failed,65 as well as attempts with added sodium acetate
to help balance abstraction of the proton, with or without degassing of solvents.
Finally, attempts to make the mono-NHC palladium complex 99 with palladium
acetate, potassium carbonate and pyridine were in accord with previous results. In
all cases, either starting material or the oxidative degradation product of the dimer,
32, resulted, which is evidence that a carbene was at least being generated. As to
their accumulative lack of success, substrates other than 41 would suffer from the
low concentration of carbene at any one time, whilst all would suffer from being
performed without true Schlenck techniques.
Silver oxide is another reagent used in the generation of NHCs. In this approach,
silver oxide reacts with NHC precursors to directly generate silver-bound NHCs.66
A theoretical study into this reaction suggested that in the first step the oxygen of
silver oxide abstracts the proton from one molecule of carbene precursor, which is
closely mapped with transfer of a silver atom to generate one equivalent of carbene
[Scheme 3.13].67 The silver hydroxide generated from the first step then abstracts
the proton from a second precursor molecule, to generate the second silver-NHC
complex and an equivalent of water. Silver-NHC bonds, however, are highly labile
and these compounds can rapidly degrade through a number of mechanisms.68 There
is a dynamic equilibrium between silver-NHC complexes such that ligand exchange
can occur. Reductive elimination of the silver from such a species would result
in formation of an NHC dimer. The main use of silver oxide in NHC chemistry,
however, is as a transmetallating agent. Silver is able to transfer NHC ligands to
other metals, such as palladium, and is a useful method for forming metal-NHC
species that are otherwise difficult to form.66,69,70
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Scheme 3.13 Synthesis of silver-NHC complexes from Ag2O
After multiple attempts and slow progress towards true Schlenck conditions, react-
ing 41 with silver oxide in degassed chloroform-d led to the generation of a new
species. By 1H-NMR spectroscopy, this was first noticeable as a new set of methyl
peaks appearing at 3.13 and 3.00 ppm. By use of correlations observed in an HMBC
experiment, it was found that these methyls were attached to a benzamide frame-
work equivalent to the starting material. The benzyl protons of this species also
had distinctly different resonances to the starting material, with two of the proton
resonances appearing as far upfield as 6.81 and 6.65 ppm. In addition to this connec-
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tivity, the two novel methyl resonances also shared HMBC correlations to another
carbon, confirming the second ring from the starting material was still present. This
carbon was found to have a shift of 106.8 ppm, a substantial difference to the shift of
153.7 ppm for the starting material. In silver-NHC complexes, the metal-bound car-
bon usually has a shift of approximately 185-195 ppm,71–73 whereas enetetramines
are somewhat more varied, with reports ranging from 100 ppm up to 125 ppm.62,74
Given the shift of this novel species falls in the range of the later, this suggests that
84 has been obtained, rather than 100 [Scheme 3.14].
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Reagents and Conditions: i. Ag2O, degassed CDCl3, rt, 2 h.
Scheme 3.14 Successful synthesis of 84
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Although symmetry elements would hinder demonstration of a dimer, MS evidence
suggests this species has been successfully synthesised. It is possible that both the E -
and Z -dimer could form, E -84 and Z -84 respectively, although the E -alkene would
be expected to form preferentially as the thermodynamic product. The nuclear Over-
hauser effect (NOE) can allow through space correlations to be observed in 1H-NMR
spectroscopy, such as might be seen between the methyls of each side of the dimer
due to their spatial proximity. Although Z -84 would not show correlations, as the
two methyls are equivalent and resonances would be obscured by the excitation pulse
of the experiment, it is possible that E -84 would show correlations between the two
methyls. Unfortunately, observation of any correlations were obscured by through-
bond coupling artifacts and the results were inconclusive. However, MS analysis
revealed the presence of a species with the molecular formula C20H20N4O2, correlat-
ing to the dimeric species 84, as three different adducts. From this NMR and MS
data, it was concluded that 2-(1,3-dimethyl-4-oxo-1,2,3,4-tetrahydroquinazolin-2-
ylidene)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one, 84, had been successfully
synthesised, as either the E - or Z -isomer. Sadly, this compound was unstable and
degraded over a period of days, such that x-ray crystallographic analysis could not
be performed to confirm this.
When performing this reaction in the additional presence of palladium acetate, a sec-
ond new species was observed. By 1H-NMR spectroscopy, 84 was observed forming
but never reached a significant concentration. Instead, two new sets of resonances
were observed forming with time. This was first observed as two new sets of methyl
resonances forming at 5.00 & 4.99 ppm, the N-1 methyl group, and at 4.69 & 4.68
ppm, the N-3 methyl group, in addition to new acetate peaks that did not correlate
to the palladium acetate starting material. Similarly in the carbon spectrum two
new sets of resonances were observed. Again, through HMBC correlations, these
were seen to have the same benzamide framework as the starting material and 84,
with noticeable changes to the aromatic region with each species having a proton
resonance above 8.2 ppm. The sets of methyl resonances each shared HMBC cor-
relations to another carbon, C-2 for each species, which here had shifts of 199.2
and 199.1 ppm. Although peaks for Pd-NHC carbons appear at around 150 ppm in
ligands where the carbene is part of an unsaturated system,75,76 saturated systems
exhibit peaks that are further downfield at approximately 200 ppm.77 Although
technically a pi-system exists in our ligand, the exocyclic carbonyl and benzene ring
would act to decrease the effect of any delocalisation. Coupled with the increased
electron-withdrawing effects of the amide and a shift of 199 ppm for the palladium
species, the structure 98 seems reasonable [Scheme 3.15].
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Scheme 3.15 Successful synthesis of 98
The two sets of resonances were reasoned as isomers of a palladium complex that
was confirmed by MS. Although the two closely related sets of methyl peaks ap-
pear as if they result from J -coupling, they are each part of two distinct molecules.
In a palladium complex with two acetate and two NHC ligands, two isomers of
the expected square planar complex can be expected: cis-98 and trans-98. Which
set of resonances were which species could potentially be assigned on the basis of
NOESY correlations, but these were again hampered by intramolecular processes
in each monomer. The suggestion of two isomers is supported by the observa-
tion of only one signficant species by MS. Here, the species with the molecular
formula of C24H26N4O6Pd was observed as both the [M+H]
+ and the more ex-
otic [M-AcOH-AcO]+ and [M-AcOH-AcO+HC(O)OH]+ species, the latter two of
which result from loss of the acetate ligands. More importantly, the M+ peak dis-
played the characteristic palladium-isotope pattern: 3.7 [M]+ : 40.8 [M+2]+ : 81.7
[M+3]+ : 100 [M+4]+ : 96.8 [M+6]+ :42.9 [M+8]+ [Figure 3.1]. Collectively, this
evidence suggests the diacetoxybis(1,3-dimethyl-4-oxo-1,2,3,4-tetrahydroquinazolin-
2-ylidene) palladium(II) 98 species was successfully obtained. Again, the compound
quickly degraded so x-ray crystallographic analysis could not be performed.
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Figure 3.1 The [M+H]+ peak for 98
Combining all the information gathered suggested that 84 and 98 were successfully
synthesised. Neither reaction was clean, with resonances resulting from the starting
material (41), the two rotomers of the hydrolysis product (28) and the oxidative
degradation product (32) all present and changing in relative amounts throughout
the course of the reaction, in addition to those of 84 and 98 which decomposed
within two days in an NMR tube under argon. Despite this, we are confident in
the assignments. These results represent the successful generation and trapping of
a carbene species in a motif that has never been demonstrated before. The ability
to generate these species shows that, under the right conditions, a carbene can be
formed in this quinazolinium-based compound, which supports the possibility of a
carbene-based mechanism occurring in the H-D exchange of these models and the
parent natural product malonganenone B. In addition, this is the first demonstration
of a new class of NHC ligand: although diamine- and diamide-ligand species have
been synthesised and complexed previously,78 this it the first time an amineamide-
ligand has been achieved.
Based on this success, the synthesis of a dimer and a palladium species from the di-
allylic compound 94 was attempted. This species has more steric protection around
the carbene centre and would be expected to show greater stability. Further, there is
the possibility that the allyl group could stabilise the metal through pi-interactions
with the alkene, acting as a bidentate ligand. Attempts to synthesise the dimer
86 from 94 and silver oxide resulted in generation only of the water adduct of the
starting material, 101, as confirmed by NMR and MS [Scheme 3.16]. Meanwhile,
attempted synthesis of the palladium species 102 using palladium acetate and silver
oxide resulted in no change. With further experimentation, these species may be
obtainable.
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Chapter 4
The H-D exchange of
malonganenone B
Kinetic evidence towards the mechanism of H-D exchange of malonganenone B (2)
was obtained. By use of NMR spectroscopy, the rate of H-D exchange was mea-
sured for various models of the exchanging moiety (23, 28 and 41) of this natural
product. Eventually, data was obtained that suggests the reaction is first order with
respect to base, which supports both a carbene and an ylide mechanism. However,
sufficiently low concentrations of the model could not be assayed using this form of
spectroscopy to allow establishment of the rate with respect to itself. Acid inhibi-
tion was also observed, in contrast to previous investigations into this reaction class.
In addition, cyclic species were observed (34 and 35), which gave evidence that an
initial cyclisation event takes place prior to H-D exchange. Further, the observation
of a cationic, carbene-precursor species (41) gave more evidence towards a carbene
mechanism being in operation.
The assignment of a carbene mechanism makes sense in view of the observations of
Simchen & co-workers. Increasing the length of the N -alkyl chain would, through
electron-donation, increase the electron density of the flanking nitrogens that would
hence be better able to stabilise the carbene. Conversely, longer O-alkyl chains
would destabilise the alkoxide leaving group, inhibiting formation of the cationic
amidine. As reported, cyclic acetals would not exchange unless a group was lost:
loss of this group is fundamental in the carbene mechanism. On the other hand,
cyclic substituents on the nitrogen were found to decrease the H-D exchange, which
is reasoned as due to inhibition of the co-planarity required for the amidinyl cation.
The carbene precursors trialled by Simchen showed no H-D exchange, but given
these had oxygen- and nitrogen-based substituents, perhaps this is evidence that
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two nitrogens are needed for sufficent stabilisation of the carbene. This concurs with
the observation of an amidine species by MS in the H-D exchange of DMFDMA.
Simchen’s acid and base results, as mentioned previously, make no sense but the
results presented here rectify this observation. It is therefore plausible that the
carbene mechanism is in operation for both DMFDMA and malonganenone B.
A carbene mechanism also seems more logical when considering other factors. Were
an ylide mechanism to be operating, a hemiaminal ester intermediate would result
with two nitrogen substituents and a hydroxyl group. In the presence of base,
it is likely the hydroxyl proton would be removed preferentially over the carbon-
bound aminal ester proton. The resultant charged species would hinder, if not
completely inhibit, formation of the proposed ylide; adjacent positive and negative
charges stabilise each other, but the same would not be expected for a positive
and two negative charges in a row! In comparison, removal of the amidine proton
from an NHC precursor would be more facile given the electron density accumulated
around the amidine. Further, when considering orbital systems, it could be imagined
that the NHC-precursor amidine would have a delocalised pi-system composed of p-
orbitals, of the nitrogens and carbonyl, and pi-bonds, of the amidine and aromatic
ring. Although this would not be an aromatic system, due to the attached aromatic
ring and the exocyclic carbonyl, the positive charge of this species would still be
stabilised through this overlap. In the case of ylide formation, however, one of the
nitrogens would be tetrahedral and the delocalised system would be lost. Finally,
the mechanisms differ only by an intramolecular elimination for the carbene and an
intermolecular protonation for the ylide. It is accepted that intramolecular reactions
hold a kinetic advantage, which further supports the carbene mechanism. This can
be concluded with the surprising statement that this combination of factors result
in breakage of a C–O bond being favoured over formation of an N–H bond.
Synthetic studies were eventually able to provide evidence of the existence of a car-
bene resulting from these species. After a slow progression of experimental design
and practices towards true Schlenck techniques, and after trialling various methods,
a fulvalene resulting from the dimerisation of two carbenes was observed (84). Re-
peated observation of the oxidative degradation product of this species was both
good indirect evidence towards its existence as well as an indicator of whether car-
benes were forming in the experiments. Given that this species was observed in
reactions without silver oxide, it can be concluded that spontaneous dimerisation of
the carbene was occurring. Through the additional presence of palladium acetate,
a palladium-NHC species was also synthesised (98). The characteristic palladium-
isotope pattern in the mass spectrum is the best evidence of this success. Given
the lack of steric protection around the carbenic carbon, it is not surprising that
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both the dimer and the palladium species were not particularly stable. In addition,
this NHC complex is likely less stable than conventional NHCs, which usually bond
strongly with metals because of the degree of electron density around the carbene
due to the flanking nitrogens. In this ligand, however, some of this density is pulled
towards the carbonyl, weakening the carbon-metal bonding and resulting in these
systems being less stable than diamino NHCs. Nonetheless, the amineamide car-
bene proposed here is a novel class of NHCs, for which this is their first successful
synthesis and demonstration. This shows that carbenes can be formed from these
species under the right conditions. Hence, if a carbene mechanism were to be in-
volved in the H-D exchange of malonganenone B, this is good evidence to support
the feasibility of such a mechanism.
The H-D exchange of malonganenone B has now been addressed. The accumulated
evidence suggests this occurs through an N-heterocyclic carbene, representing a new
class of NHCs that has never been reported [Scheme 4.1]. Although carbenes are
reactive species, it is unlikely that this is related to the biological purpose of the
secondary metabolite malonganenone B. As has been seen throughout this research,
the carbene is shortlived, particularly in the imidazole species and in nucleophilic
solvents, hence deactivation would occur before the carbene could serve any de-
fensive purpose to the organism. It is more likely, given that the head-groups of
the malonganenones and nuttingins largely resemble purines, that this is involved
in inhibition of binding to the active sites of enzymes or alternatively is involved
in signalling pathways. Were a way found to increase the life-time of the carbene
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from this species, the possibility exists that the enone present in the tail of malon-
ganenone B could trap the carbene itself in a cyclopropanation reaction. Finally,
previous research was found that examined the instance of rotamers that was so
prevalent in these analytes. Although it was observed that all peaks were doubled
in the original report of malonganenone B, this was assumed to be the appearance
of a degradation product and hindered initial isolation of this species.
Despite much failure along the way, the goal of the project was attained. Although
there were many unsuccessful attempts to obtain useful kinetic data or to trap a
carbene, this would not be the first research to contain many failures. Thomas
Edison, when confronted over his numerous failed attempts at creating the light
bulb, replied:
I have not failed. I have just found 10,000 ways to not make the light
bulb.
Yet, he needed only one way to illuminate the world. Despite much wasted time,
reagents and sanity, proof of the carbene was finally obtained. From a natural
product found in the sea off the coast of Africa, through model syntheses, kinetic
studies and repeated attempts to trap a species that may not have actually existed,
a fulvalene and a new class of organometallic ligands were obtained. Who knows
what the next natural product may bring to the world of chemistry?
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Chapter 5
Future Work
As with all projects, the more work that is done, the more work there is that needs
to be done. Regarding the initial objectives of the project, more research could be
done to finalise the assignment of the carbene mechanism. Chief among these would
be confirming those results obtained for the case of the benzene-based model, in
the cases of the imidazole-based model and the natural product malonganenone B
itself. This could include confirming the exchange is first order with respect to base
and finding a spectroscopic technique that would allow low enough concentrations
of the analyte to be observed and the order with respect to this species ascertained.
Further, a range of other bases could be trialled to try and assay the relationship
between catalysis and basicity. Similarly, quantification of acid inhibition could be
investigated.
Of more importance is exploration of this new class of NHC ligands. Attempting the
synthesis with more sterically-hindered substituents, which should convey greater
stability, would be chief among these. In addition, attempts to form alternative
metal complexes, for example with ruthenium or gold, would be of interest. Also,
copper oxide would be explored as an alternative transmetallating agent to silver
oxide. Although there is confidence in the assignment of the dimeric and palladamic
species, x-ray crystallography of an amineamide-metal complex would confirm this
beyond reasonable doubt. As with all new ligands in organometallic chemistry,
the catalytic ability of these species should be measured in a variety of reactions.
Finally, forming an organometallic complex with malonganenone B would be the
crowning achievement of this project. Given the absence of a synthetic method to
malonganenone B, more of the natural product would need to be collected from its
source on the reef of Ponto Malongane, Mozambique. Funding is to be sought for
this expedition.
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Chapter 6
Experimental
6.1 Synthesis
Unless otherwise stated, reactions were performed under air in glassware that was
not predried. Inert conditions are defined as reactions performed under argon (zero
grade) in vacuum-dried glassware using dry solvents and standard syringe tech-
niques. Tetrahydrofuran was freshly distilled from the sodium benzophenone ketyl
radical ion, and triethylamine was freshly distilled from calcium hydride. All other
reagents and solvents were used as received from commercial suppliers. Degasi-
fication was performed by the standard freeze-pump-thaw technique, with three
repetitions. Purification of products via flash chromatography was conducted using
a column filled with silica gel 60 (220-240 mesh) or DSC-Discovery Diol (Supelco).
Purification of products via reverse-phase chromatography was conducted using a
column filled with Diaion HP-20 (Supelco). 1H-NMR and 13C-NMR spectra for
structural eludications were recorded on a Varian Unity Inova 500 (500 MHz for 1H
and 125 MHz for 13C) spectrometer. 15N-NMR spectra for structural eludication,
NMR-scale reactions and NOESY spectra were recorded on a Varian DirectDrive
600 (600 MHz for 1H, 150 MHz for 13C and 60 MHz for 15N) equipped with a
Varian inverse-detected triple-resonance HCN cold probe operating at 25K. High-
resolution mass spectrometry (HRMS) was performed on a Waters Q-TOF Premier
Tandem mass spectrometer. Syntheses attempted are presented for their target com-
pound. Assignment of any byproducts produced are listed separately. Compounds
are named and numbered according to IUPAC guidelines.79
6.1.1 Imidazole-based models
N,1-dimethyl-4-(methylamino)-1H -imidazole-5-carboxamide (27)
A. Caffeine (200 mg, 1.03 mmol) was suspended in EtOH (1.6 mL), a solution of
70
NaOH (0.37 g, 9.27 mmol) in water (3.4 mL) was added and the reaction was refluxed
for three hours. The reaction was allowed to cool, neutralised with dilute HCl and
H2O (10 mL) was added. HP-20 reverse-phase chromatographic beads (6 mL) were
added and the suspension was stirred for two hours. The suspension was then
loaded on an HP-20 reverse-phase chromatographic column (30 mL) equilibrated
with water, the column was washed with water (100 mL) and eluted with CH3OH
(100 mL). The organic eluent was concentrated under reduced pressure to yield 27
(68.9 mg, 56%) as a pale yellow crystal. Recrystalisation from ethyl acetate was
unsuccessful.
B. Caffeine (10.0 g, 51.5 mmol) was added to a solution of NaOH (2.40 g, 60 mmol)
in H2O (30 mL) and refluxed for two hours. The reaction was cooled with ice, HNO3
(6.25 mL, 105 mmol) was added dropwise and the resulting white solid was filtered
and washed with water. The precipitate was dissolved in a solution of K2CO3 (6.00
g, 43.4 mmol) in H2O (20 mL), the resulting oil was extracted with CHCl3 (3 x 20
mL) and the organic phase concentrated under reduced pressure to afford a white
solid. Recrystalisation from ethyl acetate yielded 27 (3.22 g, 37%) as a white crystal.
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1H-NMR (CDCl3): δH 7.21 (s, 1H, C(2)H ), 6.98 (br s, 1H, N(N )-
H ), 3.87 (s, 3H, N(1)Me), 3.68 (br s, 1H, N(4)H ), 2.94 (d, J =
4.8 Hz, 3H, N(N )H ), 2.89 (s, 3H, N(4)Me); 13C-NMR (CDCl3):
δC 162.3 (C=O), 151.9 (C (4)), 137.3 (C (2)), 110.9 (C (5)), 34.9
(N(1)Me), 32.8 (N(4)Me), 25.7 (N(N )Me); HR-ESI-MS: C7H13N4O [M+H]
+ m/z
found 169.1086, calcd 169.1089, ∆ = -1.8 ppm.
4-[formyl(methyl)amino]-N,1-dimethyl-1H -imidazole-5-carboxamide (23)
27 (145 mg, 0.86 mmol) was suspended in formic acid (7 mL) and refluxed for 30
minutes. The reaction was concentrated under reduced pressure, H2O (5 mL) was
added and the resultant suspension filtered. The filtrate was concentrated under re-
duced pressure to yield a pale tan solid. Recrystallisation from ethyl acetate yielded
23 (10.6 mg, 6%) as a tan crystal.
B. Formic acid (2.21 mL, 58.6 mmol) and acetic anhydride (5.00 mL, 53.0 mmol)
were heated together at 55 ◦C for two hours. The reaction was cooled, 27 (3.22
g, 19.1 mmol) was added and the reaction was stirred at room temperature for 12
hours. The reaction was concentrated under reduced pressure and the resulting pale
yellow oil was crystallised from ethyl acetate to yield 23 (1.93 g, 51%) as a tan
crystal.
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Rotamer A: 1H-NMR (CDCl3): δH 8.26 (s, 1H,N4C=OH ), 7.57 (br s,
1H, N(N )H ), 7.39 (s, 1H, C(2)H ), 3.82 (s, 3H, N(1)Me), 3.36 (s, 3H,
N(4)Me), 2.84 (d, J = 5.4 Hz, 3H, N(N )Me); 1H-NMR (CD3OD):
δH 8.28 (s, 1H,N4C=OH ), 7.70 (s, 1H, C(2)H ), 3.83 (s, 3H, N(1)Me),
3.37 (s, 3H, N(4)Me), 2.84 (s, 3H, N(N )Me); 1H-NMR (DMSO−d6): δH 8.20 (s,
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1H,N4C=OH ), 7.69 (s, 1H, C(2)H ), 7.46 (br s, 1H, N(N )H ), 3.72 (s, 3H, N(1)Me),
3.26 (s, 3H, N(4)Me), 2.68 (d, J = 4.8 Hz, 3H, N(N )Me); 1H-NMR (D2O): δH 8.24
(s, 1H, N4C=OH ), 7.67 (s, 1H, C(2)H ), 3.76 (s, 3H, N(1)Me), 3.35 (s, 3H, N(4)Me),
2.83 (s, 3H, N(N )Me); 13C-NMR (CDCl3): δC 164.3 (N(4)C=O), 160.5 (C(5)C=O),
138.2 (C (2)), 136.5 (C (4)), 121.7 (C (5)), 37.4 (N(4)Me), 34.4 (N(1)Me), 26.4
(N(N )Me); 13C-NMR (DMSO−d6): δC 163.2 (N(4)C=O), 159.8 (C(5)C=O), 137.7
(C (2)), 136.9 (C (4)), 119.6 (C (5)), 35.9 (N(4)Me), 33.5 (N(1)Me), 25.8 (N(N )Me);
15N-NMR (CDCl3): δN -129 (N (3)), -217 (N (1)), -258 (N (4)), -273 (N (N )).
Rotamer B: 1H-NMR (CDCl3): δH 8.29 (s, 1H,N4C=OH ), 7.38 (s, 1H, C(2)H ),
6.02 (br s, 1H, N(N )H ), 3.91 (s, 3H, N(1)Me), 3.25 (s, 3H, N(4)Me), 2.93 (d, J
= 5.4 Hz, 3H, N(N )Me); 1H-NMR (CD3OD): δH 8.25 (s, 1H,N4C=OH ), 7.67 (s,
1H, C(2)H ), 3.82 (s, 3H, N(1)Me), 3.21 (s, 3H, N(4)Me), 2.86 (s, 3H, N(N )Me);
1H-NMR (DMSO−d6): δH 8.18 (s, 1H, N4C=OH ), 7.96 (br s, 1H, N(N )H ), 7.68
(s, 1H, C(2)H ), 3.70 (s, 3H, N(1)Me), 3.07 (s, 3H, N(4)Me), 2.72 (d, J = 4.5 Hz,
3H, N(N )Me); 1H-NMR (D2O): δH 8.22 (s, 1H, N4C=OH ), 7.64 (s, 1H, C(2)H ),
3.75 (s, 3H, N(1)Me), 3.18 (s, 3H, N(4)Me), 2.86 (s, 3H, N(N )Me); 13C-NMR
(CDCl3): δC 163.8 (N(4)C=O), 159.9 (C(5)C=O), 141.3 (C (4)), 138.4 (C (2)), 118.4
(C (5)), 35.3 (N(1)Me), 32.6 (N(4)Me), 26.3 (N(N )Me); 13C-NMR (DMSO−d6): δC
162.5 (N(4)C=O), 159.8 (C(5)C=O), 140.4 (C (4)), 138.0 (C (2)), 117.7 (C (5)), 33.8
(N(1)Me), 31.5 (N(4)Me), 25.8 (N(N )Me); 15N-NMR (CDCl3): δN -127 (N (3)), -
215 (N (1)), -262 (N (4)), -281 (N (N )).
HR-ESI-MS: C8H13N4O
+
2 [M+H]
+ m/z found 197.1033, calcd 197.1039, ∆ = 3.0
ppm; HR-ESI-MS: C8H12N4O2Na
+ [M+Na]+ m/z found 219.0856, calcd 219.0858,
∆ = -0.9 ppm.
4-[(2H)formyl(methyl)amino]-N,1-dimethyl-1H -imidazole-5-carboxamide
(103)
23 (6.0 mg, 0.0306 mmol) was dissolved in CD3OD (0.55 mL) in an NMR tube and
left to equilibrate for 5 days. The reaction was concentrated under reduced pressure
to yield 103 as a white solid in quantitative yield.
1
2
N3 4
N 5
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Rotamer A: 1H-NMR (CDCl3): δH 7.57 (br s, 1H, N(N )H ), 7.38
(s, 1H, C(2)H ), 3.81 (s, 3H, N(1)Me), 3.39 (s, 3H, N(4)Me), 2.81
(d, J = 5.5 Hz, 3H, N(N )Me); 1H-NMR (CD3OD): δH 7.71 (s, 1H,
C(2)H ), 3.83 (s, 3H, N(1)Me), 3.34 (s, 3H, N(4)Me), 2.85 (s, 3H,
N(N )Me); 1H-NMR (D2O): δH 7.66 (s, 1H, C(2)H ), 3.74 (s, 3H, N(1)Me), 3.38
(s, 3H, N(4)Me), 2.83 (s, 3H, N(N )Me); 13C-NMR (CDCl3): δC 164.1 (N(4)C=O),
160.4 (C(5)C=O), 138.2 (C (2)), 136.7 (C (4)), 121.6 (C (5)), 37.3 (N(4)Me), 34.4
(N(1)Me), 26.2 (N(N )Me).
Rotamer B: 1H-NMR (CDCl3): δH 7.37 (s, 1H, C(2)H ), 6.01 (br s, 1H, N(N )H ),
3.90 (s, 3H, N(1)Me), 3.27 (s, 3H, N(4)Me), 2.94 (d, J = 5.5 Hz, 3H, N(N )Me);
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1H-NMR (CD3OD): δH 7.68 (s, 1H, C(2)H ), 3.79 (s, 3H, N(1)Me), 3.22 (s, 3H,
N(4)Me), 2.88 (s, 3H, N(N )Me); 1H-NMR (D2O): δH 7.63 (s, 1H, C(2)H ), 3.76 (s,
3H, N(1)Me), 3.21 (s, 3H, N(4)Me), 2.86 (s, 3H, N(N )Me); 13C-NMR (CDCl3): δC
163.9 (N(4)C=O), 160.0 (C(5)C=O), 141.3 (C (4)), 138.4 (C (2)), 118.5 (C (5)),
35.2 (N(1)Me), 32.9 (N(4)Me), 26.1 (N(N )Me). HR-ESI-MS: C8H11DN4O2Na
[M+Na]+ m/z found 220.0919, calcd 220.0921, ∆ = -0.9 ppm.
6.1.2 Benzene-based models
1,3-dimethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione (32)
A. Under inert conditions benzoylene urea (0.83 g, 5.1 mmol) was dissolved in
DMF (100 mL), K2CO3 (2.89 g, 20.91 mmol) and MeI (1.27 mL, 20.41 mmol) were
added and the reaction stirred at room temperature for 36 hours. The reaction was
filtered, HP20 beads (10 mL) were added and the suspension slowly diluted with
H2O until the concentration was approximately 5% DMF v/v. The suspension was
then loaded onto a column of HP20 beads (60 mL) equilibrated with water. The
column was washed with H2O (300 mL), eluted with acetone (300 mL) and the
eluent was concentrated under reduced pressure. Tituration from ethyl acetate with
petroleum ether yielded 32 as a white powder (613 mg, 63%).
B. Under inert conditions 41 (110 mg, 0.52 mmol) was dissolved in THF (2 mL),
NaH (25 mg, 1.04 mmol) was added and the reaction was stirred for 4 hours at 50 ◦C.
The reaction was concentrated under reduced pressure, the residue was extracted
with hot toluene and the organic phase was concentrated under reduced pressure to
give a white solid. Purification by flash chromatography yielded 32 (54.4 mg, 55%)
as a white solid.
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1H-NMR (CDCl3): δH 8.22 (dd, J = 7.8, 1.7 Hz, 1H, C(5)H ),
7.67 (ddd, J = 8.5, 7.3, 1.7 Hz, 1H, C(7)H ), 7.26 (ddd, J =
8.0, 7.2, 1 Hz, 1H, C(6)H ), 7.20 (d, J = 8.3 Hz, 1H, C(8)H ),
3.61 (s, 3H, N(1)Me), 3.49 (s, 3H, N(3)Me); 13C-NMR (CDCl3):
δC 161.9 (C (4)), 151.2 (C (2)), 140.4 (C (8a)), 135.0 (C (7)), 128.9 (C (5)), 122.9
(C (6)), 115.4 (C (4a)), 113.5 (C (8)), 30.8 (N(1)Me), 28.5 (N(3)Me); HR-ESI-MS:
C10H10N2O2Na
+ [M+Na]+ m/z found 213.0645, calcd 213.0640, ∆ = 2.3 ppm.
N -methyl-2-(methylamino)benzamide (30)
A. N -methylanthranilic acid (30 mg, 0.2 mmol) was dissolved in SOCl2 (5 mL) and
refluxed for 3 hours. The reaction was concentrated under reduced pressure, THF
(6 mL) was added and the solution was cooled. Aq. CH3NH2 (3.5 mL, 40% v/v, 41
mmol) was added dropwise and the reaction was stirred at room temperature for 12
hours. Extractions with CHCl3 and ethyl acetate yielded no product.
B. 32 (100 mg, 0.53 mmol) was dissolved in aq. NaOH (0.655 mL, 2M, 1.31 mmol)
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and refluxed for 36 hours. The reaction was cooled and saturated NH4Cl (5 mL)
was added. The solution was extracted with CH2Cl2 (3 x 5 mL) and the combined
organic phases were concentrated under reduced pressure to yield 30 as a white
crystal (79 mg, 92%).
C. N -methylisatoic anhydride (9 g, 50.8 mmol) was dissolved in H2O (26.6 mL), aq.
CH3NH2 (9.62 mL, 40% w/w., 124 mmol) was added and the reaction was stirred at
50 ◦C for 1 hour. The reaction was cooled, diluted with H2O (50 mL) and extracted
with ethyl acetate (50 mL x 2). The combined organic phases were washed with sat.
aq. NH4Cl (50 mL x 2), H2O (50 mL x 2), brine (50 mL x 2), dried over MgSO4,
filtered and the filtrate concentrated under reduced pressure to yield 30 as a white
powder (8.17 g, 98%).
N
H
NH
O
1
6
5
4
3
2
1H-NMR (CDCl3): δH 7.42 (br s, 1H, N(2)H ), 7.31 (t, J = 8.0 Hz,
1H, C(4)H, 7.30 (d, 7.6 Hz, 1H, C(6)H ), 6.66 (d, J = 8.3 Hz, 1H,
C(3)H ), 6.56 (t, J = 7.3 Hz, 1H, C(5)H ), 6.12 (br s, 1H, N(N )H ),
2.94 (d, J = 4.9 Hz, 3H, N(N )Me), 2.85 (br s, 3H, N(N )Me);
13C-NMR (CDCl3): δC 170.7 (C=O), 150.5 (C (2)), 132.8 (C (4)), 127.2 (C (6)),
115.4 (C (1)), 114.6 (C (5)), 111.2 (C (3)), 29.8 (N(2)Me), 26.6 (N)(N )Me); HR-
ESI-MS: C9H12N2ONa [M+Na]
+ m/z found 187.0850, calcd 187.0847, ∆ = 1.6
ppm; HR-ESI-MS: C9H13N2O [M+H]
+ m/z found 165.1031, calcd 165.1028, ∆ =
1.8 ppm.
N -methyl-2-(N -methylformamido)benzamide(28)
Formic acid (1.15 mL, 30.42 mmol) and acetic anhydride (2.61 mL, 27.65 mmol) were
heated together for 2 hours at 55 ◦C. The reaction was cooled, 30 was added and the
reaction stirred at room temperature for 12 hours. The reaction was concentrated
under reduced pressure and purified by flash chromatography to yield 28 as a white
crystal (2.42 g, 86.2%).
N
H
N
O
O
H
2
1
3
6
5
4
Rotamer A: 1H-NMR (CDCl3): δH 8.27 (s, 1H, N(2)C(O)H ), 7.64
(dd,J = 7.5, 1.7 Hz, 1H, C(6)H ), 7.51 (dt, J = 7.8, 1.7 Hz, 1H,
C(4)H ), 7.41 (dt, J = 7.5, 1.2 Hz, 1H, C(5)H ), 7.20 (dd, J = 7.8,
1.0 Hz, 1H, C(3)H ), 5.85 (br s, 1H, N(N )H ), 3.26 (s, 3H, N(2)Me),
2.99 (s, 3H, N(N )Me); 1H-NMR (CD3OD): δH 8.15 (s, 1H, N2C(O)H ), 7.59–7.51
(m, 2H, C(4)H, C(6)H ), 7.45 (dt, J = 7.3, 1.2 Hz, 1H, C(5)H ), 7.37 (dd, J = 7.9,
0.9 Hz, 1H, C(3)H ), 3.20 (s, 3H, N(2)Me), 2.87 (s, 3H, N(N )Me); 1H-NMR (D2O):
δH 7.98 (s, 1H, N2C(O)H ), 7.50–7.45 (m, 1H, C(6)H, C(4)H or C(5)H ), 7.42–7.34
(m, 2H, C(6)H, C(4)H or C(5)H ), 7.25 (dd, J = 8.0, 0.7 Hz, 1H, C(3)H ), 3.03
(s, 3H, N(2)Me), 2.73 (s, 3H, N(N )Me); 13C-NMR (CDCl3): δC 167.6 (C(1)C=O),
162.6 (N(2)C=O), 139.4 (C (2)), 133.7 (C (1)), 131.5 (C (4)), 129.3 (C (6)), 128.1
(C (5)), 127.6 (C (3)), 33.8 (N(2)Me), 27.0 (N(N )Me).
Rotamer B: 1H-NMR (CDCl3): δH 8.25 (s, 1H, N(2)C(O)H ), 7.55 (dd,J = 7.6, 1.2
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Hz, 1H, C(6)H ), 7.51 (dt, J = 7.8, 1.4 Hz, 1H, C(4)H ), 7.41 (dt, J = 7.5, 1.2 Hz, 1H,
C(5)H ), 7.18 (dd, J = 8.0, 1.2 Hz, 1H, C(3)H ), 6.30 (br s, 1H, N(N )H ), 3.33 (s, 3H,
N(2)Me), 2.93 (s, 3H, N(N )Me); 1H-NMR (CD3OD): δH 8.19 (s, 1H, N(2)C(O)H ),
7.59–7.51 (m, 2H, C(4)H, C(6)H ), 7.45 (dt, J = 7.3, 1.2 Hz, 1H, C(5)H ), 7.32 (d,
J = 8.2 Hz, 1H, C(3)H ), 3.37 (s, 3H, N(2)Me), 2.84 (s, 3H, N(N )Me); 1H-NMR
(D2O): δH 8.04 (s, 1H, N(2)C(O)H ), 7.50–7.45 (m, 1H, C(6)H, C(4)H or C(5)H ),
7.42–7.34 (m, 2H, C(6)H, C(4)H or C(5)H ), 7.22 (d, J = 8.1 Hz, 1H, C(3)H ), 3.21
(s, 3H, N(2)Me), 2.71 (s, 3H, N(N )Me); 13C-NMR (CDCl3): δC 168.5 (C(1)C=O),
163.3 (N(2)C=O), 137.0 (C (2)), 136.2 (C (1)), 131.3 (C (4)), 128.7 (C (6)), 128.7
(C (5)), 127.8 (C (3)), 38.5 (N(2)Me), 26.7 (N(N )Me).
HR-ESI-MS: C12H13N2O2 [M+H]
+ m/z found 193.0983, calcd 193.0977, ∆ = 3.1
ppm; HR-ESI-MS: C12H12N2O2Na [M+Na]
+ m/z found 215.0798, calcd 215.0796,
∆ = 0.9 ppm
N -methyl-2-(N -methyl(2H)formamido)benzamide (49)
28 (6 mg, 0.031 mmol) was dissolved in D2O (0.55 mL) and allowed to equilibrate
for 22 hours. The reaction was concentrated under reduced pressure to yield 49 as
a white crystal in quantitative yield.
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Rotamer A: 1H-NMR (CDCl3): δH 7.64 (dd,J = 7.5, 1.7 Hz, 1H,
C(6)H ), 7.51 (dt, J = 7.8, 1.7 Hz, 1H, C(4)H ), 7.41 (dt, J = 7.5, 1.2
Hz, 1H, C(5)H ), 7.20 (dd, J = 7.8, 1.0 Hz, 1H, C(3)H ), 5.85 (br s,
1H, N(N )H ), 3.26 (s, 3H, N(2)Me), 2.99 (s, 3H, N(N )Me); 1H-NMR
(D2O): δH 7.46 (dt, J = 7.8, 1.9 Hz, 1H, C(5)H ), 7.42–7.33 (m, 2H, C(4)H, C(6)H ),
7.25 (dd, J = 7.9, 0.7 Hz, 1H, C(3)H ), 3.21 (s, 3H, N(2)Me), 2.73 (s, 3H, N(N )Me);
13C-NMR (CDCl3): δC 167.6 (C(1)C=O), 162.8 (N(2)C=O), 139.4 (C (2)), 133.7
(C (1)), 131.5 (C (4)), 129.3 (C (6)), 128.1 (C (5)), 127.6 (C (3)), 33.8 (N(2)Me),
27.0 (N(N )Me); 13C-NMR (D2O): δC 170.7 (C(1)C=O), 165.2 (N(2)C=O), 138.4
(C (2)), 132.6 (C (1)), 131.8 (C (4)), 128.6 (C (6)), 128.3 (C (5)), 127.3 (C (3)), 33.5
(N(2)Me), 26.2 (N(N )Me).
Rotamer B: 1H-NMR (CDCl3): δH 7.55 (dd,J = 7.6, 1.2 Hz, 1H, C(6)H ), 7.51 (dt,
J = 7.8, 1.4 Hz, 1H, C(4)H ), 7.41 (dt, J = 7.5, 1.2 Hz, 1H, C(5)H ), 7.18 (dd, J
= 8.0, 1.2 Hz, 1H, C(3)H ), 6.30 (br s, 1H, N(N )H ), 3.33 (s, 3H, N(2)Me), 2.93
(s, 3H, N(N )Me); 1H-NMR (D2O): δH 7.48 (dt, J = 7.5, 1.7 Hz, 1H, C(5)H ),
7.42–7.33 (m, 2H, C(4)H, C(6)H ), 7.22 (dd, J = 7.8, 0.7 Hz, 1H, C(3)H ), 3.19 (s,
3H, N(2)Me), 2.71 (s, 3H, N(N )Me); 13C-NMR (CDCl3): δC 168.5 (C(1)C=O),
163.4 (N(2)C=O), 137.0 (C (2)), 136.2 (C (1)), 131.3 (C (4)), 128.7 (C (6)), 128.7
(C (5)), 127.8 (C (3)), 38.5 (N(2)Me), 26.7 (N(N )Me); 13C-NMR (D2O): δC 170.6
(C(1)C=O), 164.8 (N(2)C=O), 136.5 (C (2)), 133.3 (C (1)), 132.0 (C (4)), 128.8
(C (6)), 128.2 (C (5)), 127.5 (C (3)), 38.0 (N(2)Me), 26.1 (N(N )Me).
HR-ESI-MS: C10H12DN2O2 [M+H]
+ m/z found 194.1042, calcd 194.1040, ∆ = 1.0
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ppm.
2-(2H3)methoxy-1,3-dimethyl-2-
2H-1,3,4-trihydroquinazolin-4-one (34)
28 (6 mg, 0.031 mmol) was dissolved in CD3OD (0.55 mL) and left to equilibrate
for 20 hours. Removal of the solvent under reduced pressure yielded 34 as a white
solid in quantitative yield.
N
N
O
OCD3
D8
7
6
5
4a
8a
4
1
3
2
1H-NMR (CDCl3): δH 8.01 (d, J = 7.8 Hz, 1H, C(5)H ), 7.42
(t, J = 7.1 Hz, 1H, C(7)H ), 6.87 (t, J = 7.6 Hz, 1H, C(6)H ),
6.68 (d, J = 8.3 Hz, 1H, C(8)H ), 3.15 (s, 3H, N(1)Me), 3.04
(s, 3H, N(3)Me); 1H-NMR (CD3OD): δH 7.87 (d, J = 7.8 Hz,
1H, C(5)H ), 7.48 (t, J = 7.4 Hz, 1H, C(7)H ), 6.88 (t, J =7.8 Hz, 1H, C(6)H ),
6.85 (d, J = 8.0 Hz, 1H, C(8)H ), 3.15 (s, 3H, N(1)Me), 3.10 (s, 3H, N(3)Me);
13C-NMR (CDCl3): δC 162.5 (C (4)), 145.3 (C (8a)), 134.2 (C (7)), 128.5 (C (5)),
118.3 (C (6)), 113.8 (C (4a)), 110.2 (C (8)), 96.9 (C (2)), 49.3 (OMe), 34.7 (N(3)Me),
32.3 (N(1)Me); 13C-NMR (CD3OD): δC 164.7 (C (4)), 146.9 (C (8a)), 135.6 (C (7)),
128.7 (C (5)), 119.1 (C (6)), 114.8 (C (4a)), 112.2 (C (8)), 98.4 (C (2)), 35.3 (OMe),
35.3 (N(3)Me), 32.8 (N(1)Me).
2-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one (35)
Under inert conditions and with 3 A˚molecular sieves, 28 (135 mg, 0.70 mmol) was
dissolved in CH3OH (25 mL) and the reaction stirred at room temperature for 12
hours. The reaction was filtered and the filtrate concentrated under reduced pressure
to yield a colourless oil that was a mixture of 35 and 28 (1:1.35 ratio).
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1H-NMR (CDCl3): δH 7.96 (d, J = 7.8 Hz, 1H, C(5)H ), 7.41
(t, J = 8.3 Hz, 1H, C(7)H ), 6.85 (t, J = 7.5 Hz, 1H, C(6)H ),
6.67 (d, J = 8.3 Hz, 1H, C(8)H ), 5.77 (s, 1H, C(2)H ), 3.13
(s, 3H, N(3)Me), 3.03 (s, 3H, N(1)Me), 2.93 (S, 3H, OMe);
13C-NMR (CDCl3): δC 163.0 (C (4)), 145.2 (C (8a)), 134.2 (C (7)), 128.3 (C (5)),
118.2 (C (6)), 113.5 (C (4a)), 110.2 (C (8)), 96.8 (C (2)), 49.3 (OMe), 34.6 (N(1)Me),
32.2 (N(3)Me).
6.1.3 Quinazolinium-based models
Attempted synthesis of (1,3-dimethyl-4-oxo-1,2,3,4-tetrahydroquinazolin-
2-yl)oxidanesulfonic acid (42)
N
N
O
OSO2OH
H
Under inert conditions, 28 (30 mg, 0.156 mmol) was dissolved
in DMF (2 mL), SO3 · pyridine complex (99 mg, 0.624 mmol)
was added and the reaction was stirred at rt for 4 days. The
reaction was concentrated under reduced pressure to yield
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starting material.
1,3-dimethyl-4-oxo-3,4-dihydroquinazolin-1-ium chloride (41)
A. 28 (30 mg, 0.156 mmol) was suspended in ethylchloroformate (0.3 mL, 3.12
mmol), pyridine (15 µL, 0.187 mmol) was added and the reaction refluxed for 4
days. H2O (2 mL) was added and the reaction mixture was concentrated under
reduced pressure to yield an oil which proved to be a mixture of 41 and pyridine
(1:2.4, 57 mg, 98%).
B. Under inert conditions, 28 (400 mg, 2.08 mmol) was suspended in ethylchlorofor-
mate (8 mL, 84 mmol) and stirred overnight at 50 ◦C. The reaction was concentrated
under reduced pressure and the resulting solid was rinsed with ethyl acetate (5 mL
x 2). The liquid phase was decanted off to yield 41 as a white solid (379 mg, 86 %).
C. Under inert conditions 4-hydroxyquinazoline (500 mg, 3.42 mmol), NaHCO3 (570
mg, 6.84 mmol) and MeI (10 mL, 160 mmol) were combined in a pressure tube. The
tube was sealed and heated with stirring at 55 ◦C for 4 days. The reaction was
partitioned (30 mL each) with diethyl ether, ethyl acetate, CH3OH then H2O, in
that order. The insoluble purple precipitate resulting from the addition of H2O was
filtered and showed the presence of 41, as the iodide salt, and 28. Further purifica-
tion was unsuccessful.
D. Under inert conditions 30 (24 mg, 0.132 mmol) was dissolved in CH3OH (0.75
mL), 15 (52 µL, 0.39 mmol) and formic acid (17 µL, 0.43 mmol) were added and
the reaction stirred at room temperature for 2 days. The reaction was concentrated
under reduced pressure to yield 46 in quantitative yield. NEt3 (50 µL) was added
to attempt to complete the synthesis, however the sample quickly degraded back to
30.
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1H-NMR (CDCl3): δH 12.3 (s, 1H, C(2)H ), 8.45 (d, J = 8.6
Hz, 1H, C(8)H ), 8.03 (t, J = 7.3 Hz, 1H, C(6)H ), 7.80 (t, J
= 7.5 Hz, 1H, C(7)H ), 7.74 (d, J = 8.1 Hz, 1H, C(5)H ), 4.41
(s, 3H, N(3)Me), 3.98 (s, 3H, N(1)Me); 13C-NMR (CHCl3):
δC 157.8 (C (8a)), 155.2 (C (2)), 138.2 (C (4)), 137.0 (C (5)), 130.1 (C (6)), 129.2
(C (8)), 119.7 (C (4a)), 117.3 (C (7)), 40.4 (N(3)Me), 36.3 (N(1)Me); HR-ESI-MS:
C10H11N2O
+ [M]+ m/z found 175.0874, calcd 175.0871, ∆ = 1.7 ppm.
2-[(dimethoxymethyl)(methyl)amino]-N -methylbenzamide (46)
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1H-NMR (CDCl3): δH 8.44 (s, 1H, N(2)CH ), 7.32–7.30 (m, 2H,
C(4)H, C(6)H ), 6.66 (d, J = 8.6 Hz, 1H, C(3)H ), 6.57 (t, J =
7.6 Hz, 1H, C(5)H ), 2.95 (d, J = 4.6 Hz, 3H, N(N )Me), 2.85 (s,
3H, N(2)Me), 2.64 (s, 6H, N(2)C(OMe)2).
2-2H-1,3-dimethyl-4-oxo-3,4-dihydroquinazolin-1-ium chloride (50)
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41 (6 mg, 0.0286 mmol) was dissolved in D2O (0.55 mL) and allowed to equilibrate
for 4 hours. The reaction was concentrated under reduced pressure to yield 50 as a
white crystal in quantitative yield.
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1H-NMR (CDCl3): δH 8.45 (d, J = 8.6 Hz, 1H, C(8)H ), 8.03
(t, J = 7.3 Hz, 1H, C(6)H ), 7.80 (t, J = 7.5 Hz, 1H, C(7)H ),
7.74 (d, J = 8.1 Hz, 1H, C(5)H ), 4.41 (s, 3H, N(3)Me), 3.98
(s, 3H, N(1)Me); 13C-NMR (CHCl3): δC 157.8 (C (8a)), 155.3
(C (2)), 138.2 (C (4)), 137.0 (C (5)), 130.1 (C (6)), 129.2 (C (8)), 119.7 (C (4a)), 117.3
(C (7)), 40.4 (N(3)Me), 36.3 (N(1)Me).
Attempted synthesis of 1,3,7-trimethyl-6-oxo-6,7-dihydro-1H -purin-3- ium
chloride (47)
N
NN
N
O
H
Cl
A. Under inert conditions in a distillation apparatus, 27 (394
mg, 2.34 mmol) was dissolved in CH3OH (1 mL), DMFDMA
(0.318 µL, 2.38 mmol) was added and the reaction was heated
at 75 ◦C for 6 hours. The reaction was distilled to yield a golden
oil residue composed of 48 and 23. Addition of formic acid (0.25 mL) and CH3OH
(1 mL) led to the formation of 47, however this quickly degraded.
2-methoxy-1,3,7-trimethyl-1,2,3,6-tetrahydro-1H -purin-6-one (48)
N
N
O
N
N9
6
5
4 3 2
1
H
O
8
7
1H-NMR (CDCl3): δH 7.18 (s, 1H, C(8)H ), 5.77 (s, 1H, C(2)H ),
3.86 (s, 3H, N(7)Me), 3.14 (s, 3H, N(3)Me), 3.08 (s, 3H, OMe),
3.07 (s, 3H, N(1)Me); 13C-NMR (CDCl3): δC 157.9 (C (6)), 152.9
(C (4)), 139.2 (C (8)), 137.4 (C (5)), 99.0 (C (2)), 50.0 (OMe), 34.8
(N(7)Me), 32.4 (N(3)Me), 31.1 (N(1)Me).
6.1.4 Trapping a carbene
As a cyclopropane
Attempted synthesis of 2-(hydroxymethyl)-1’,3’,7’-trimethyl-3’,7’-
dihydrospiro[cyclopropane-1,2’-purin]-6’(1’H)-one (57)
N
N N
N
O
OH
In an NMR tube 23 (6.4 mg, 0.032 mmol) was dissolved in
CD3OD (0.55 mL), allyl alcohol (22.7 µL, 0.33 mmol) was
added and the reaction was followed by NMR spectroscopy for
5 days. Decrease of the formyl resonance was the only observ-
able change.
Attempted synthesis of 1’,3’,7’-trimethyl-1’,3’,4’,5’,6’,7’-hexahydrospiro
[bicyclo[3.1.0]hexane-6,2’-purine]-6’-one (58)
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NN N
N
O In an NMR tube 23 (6.4 mg, 0.032 mmol) was dissolved in CD3OD
(0.55 mL), cyclopentene (32.0 µL, 0.35 mmol) was added and the
reaction was followed by NMR spectroscopy for 7 days. Decrease
of the formyl resonance was the only observable change.
Attempted synthesis of 3-(dimethylamino)-3-methoxycyclopropane-
1,1,2,2-tetracarbonitrile (62)
N O
NC
NC
CN
CN A. 15 (22.5 µL, 0.168 mmol) was dissolved in CH2Cl2 (2 mL) with
tetracyanoethylene (65 mg, 0.507 mmol) and stirred at room temper-
ature under argon for three months. No change was observed by TLC
analysis.
B. 15 (22.5 µL, 0.168 mmol) was dissolved in THF (2 mL) with tetracyanoethylene
(65 mg, 0.507 mmol) and stirred at room temperature under argon for three months.
No change was observed by TLC analysis.
Attempted synthesis of ethyl 3-(dimethylamino)-3-methoxy-2-(propanoyl
oxy)cycloprop-1-ene-1-carboxylate (61)
N O
O
O
O
O
A. 15 (22.5 µL, 0.168 mmol) was dissolved in CH2Cl2
(2 mL) with diethylacetylene dicarbonate (81 µL, 0.506
mmol) and stirred at room temperature under argon for
three months. No change was observed by TLC analysis.
B. 15 (22.5 µL, 0.168 mmol) was dissolved in THF (2 mL) with diethylacetylene
dicarbonate (81 µL, 0.506 mmol) and stirred at room temperature under argon for
three months. No change was observed by TLC analysis.
C. 15 (22.5 µL, 0.168 mmol) was dissolved in diethylacetylene dicarbonate (200 µL,
1.25 mmol) and stirred at room temperature under argon for three months. No
change was observed by TLC analysis.
Attempted synthesis of diethyl 3-butyl-2-(dimethylamino)-2-methoxy
cyclopropane-1-carbaldehyde (63)
N O
O A. 15 (22.5 µL, 0.168 mmol) was dissolved in CH2Cl2 (2 mL)
with hept-2-en-1-al (66 µL, 0.504 mmol) and stirred at room
temperature under argon for three months. No change was ob-
served by TLC analysis.
B. 15 (22.5 µL, 0.168 mmol) was dissolved in THF (2 mL) with hept-2-en-1-al (66
µL, 0.504 mmol) and stirred at room temperature under argon for three months.
No change was observed by TLC analysis.
Attempted synthesis of 1’,3’-dimethyl-4’-oxo-3’,4’-dihydro-1’H -
spiro[cyclopropane-1,2’-quinazoline]-2,2,3,3-tetracarbonitrile (65)
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NN
O
CN
CN
NC CN
A. 28 (20 mg, 0.104 mmol) was dissolved in CH2Cl2 (2 mL)
with tetracyanoethylene (40 mg, 0.312 mmol) and stirred at
room temperature under argon for three months. No change
was observed by TLC analysis.
B. 28 (20 mg, 0.104 mmol) was dissolved in THF (2 mL) with tetracyanoethylene
(40 mg, 0.312 mmol) and stirred at room temperature under argon for three months.
No change was observed by TLC analysis.
C. Under inert conditions, 28 (40 mg, 0.208 mmol) was suspended in ethylchloro-
formate (1.9 mL) and stirred at 50 ◦C for 12 hours. The reaction was concentrated
under reduced pressure to yield 41. This was dissolved in THF (2 mL), tetracya-
noethylene (133 mg, 1.04 mmol) and NaH (10 mg, 0.416 mmol) were added and the
reaction stirred at room temperature overnight. The reaction was filtered and the
precipitate washed with acetonitrile. The combined filtrate was concentrated under
reduced pressure to yield a brown solid that was predominantly 41.
(D). Under inert conditions 41 (37.2 mg, 0.177 mmol) was dissolved in degassed
THF (24 mL) and tetracyanoethylene (23 mg, 0.177 mmol) was added. NaH (13.2
mg, 0.531 mmol) suspended in degassed THF (6 mL) was added and the reaction
was stirred at room temperature for 8 days. The reaction was quenched with H2O
(10 mL), concentrated under reduced pressure and extracted into ethyl acetate (20
mL). The organic phase was washed with brine, dried over MgSO4, filtered and the
filtrate concentrated under reduced pressure to yield an oil that was largely com-
posed of 30.
(E). Under inert conditions 41 (240 mg, 1.14 mmol) was dissolved in degassed THF
(24 mL), tetracyanoethylene (146 mg, 1.14 mmol) and NEt3 (320 µL, 2.28 mmol)
were added and the resulting crimson solution was stirred at room temperature for
9 days. The reaction was quenched with H2O (10 mL), concentrated under reduced
pressure and extracted into ethyl acetate (20 mL). The organic phase was washed
with brine, dried over MgSO4, filtered and the filtrate concentrated under reduced
pressure to give an oil that was largely composed of 28.
Attempted synthesis of 2,3-diethyl-1’,3’-dimethyl-4’-oxo-3’,4’-dihydro-
1’H -spiro[cyclopropane-1,2’-quinazolin]-2-ene-2,3-dicarboxylate (64)
N
N
O
OO
O
O
A. 28 (20 mg, 0.104 mmol) was dissolved in CH2Cl2 (2 mL)
with diethylacetylene dicarbonate (50 µL, 0.312 mmol) and
stirred at room temperature under argon for three months. No
change was observed by TLC analysis.
B. 28 (20 mg, 0.104 mmol) was dissolved in THF (2 mL) with
diethylacetylene dicarbonate (50 µL, 0.312 mmol) and stirred
at room temperature under argon for three months. No change was observed by
TLC analysis.
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C. 28 (20 mg, 0.104 mmol) was dissolved in diethylacetylene dicarbonate (100 µL,
0.625 mmol) and stirred at room temperature under argon for three months. No
change was observed by TLC analysis.
D. Under inert conditions 28 (40 mg, 0.208 mmol) was suspended in ethylchloro-
formate (1.9 mL) and stirred at 50 ◦C for 12 hours. The reaction was concentrated
under reduced pressure to yield 41. This was dissolved in THF (2 mL), tetracya-
noethylene (133 mg, 1.04 mmol) and NaH (10 mg, 0.416 mmol) were added and the
reaction stirred at room temperature overnight. The reaction was filtered and the
precipitate was washed with acetonitrile. The combined filtrate was concentrated
under reduced pressure to yield a brown solid that was an indistinquishable mess.
Attempted synthesis of 2-butyl-1’,3’-dimethyl-4’-oxo-3’,4’-dihydro- 1’H -
spiro[cyclopropane-1,2’-quinazoline]-3-carbaldehyde (66)
N
N
O
O
A. 28 (20 mg, 0.104 mmol) was dissolved in CH2Cl2 (2 mL)
with hept-2-en-1-al (41 µL, 0.313 mmol) and stirred at room
temperature under argon for three months. No change was ob-
served by TLC analysis.
B. 28 (20 mg, 0.104 mmol) was dissolved in THF (2 mL) with
hept-2-en-1-al (41 µL, 0.313 mmol) and stirred at room temperature under argon
for three months. No change was observed by TLC analysis.
Attempted synthesis of 1’,3’-dimethyl-4’-oxo-2-propyl-3’,4’-dihydro-1’H -
spiro[cyclopropane-1,2’-quinazoline]-3-carbaldehyde (67)
N
N
O
O
28 (20 mg, 0.104 mmol) was dissolved in THF (2 mL) with 2-
hexenal (36 µL, 0.310 mmol) and stirred at room temperature
under argon for three months. No change was observed by TLC
analysis.
Attempted synthesis of 1’,3’-dimethyl-3’,4’-dihydro-1’H -
spiro[bicyclo [3.1.0]hexane-6,2’-quinazolin]-2-en-4’-one (68)
N
N
O Formic acid (0.133 mL, 3.54 mmol) and acetic anhydride (0.3 mL,
3.21 mmol) were stirred together at 55 ◦C for 2 hours. The reac-
tion was cooled to room temperature, 30 (79 mg, 0.487 mmol) was
added and the reaction stirred at 25 ◦C for 12 hours. The reaction
was concentrated under reduced pressure, 43 mg of the resultant 28 product was
dissolved in CH3OH (1.3 mL), cyclopentadiene (1 mL, 11.89 mmol) was added and
the reaction was stirred at room temperature for 5 days. No change was observed
by TLC and NMR spectroscopic analysis.
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Attempted synthesis of 2-ethoxy-1’,3’-dimethyl-3’,4’-dihydro-1’H -spiro-
cyclopropane-1,2’-quinazoline
-4’-one (71)
N
N
O
O
Under inert conditions 41 (20 mg, 0.094 mmol) was dissolved
in degassed THF (5 mL), ethyl vinyl ether (20 µL, 0.209
mmol) and NaH (5 mg, 0.113 mmol) were added and the
reaction was stirred at room temperature for 2 days. The
reaction was concentrated under reduced pressure, toluene (5 mL) was added and
the resulting precipitate filtered off. The filtrate was concentrated under reduced
pressure and purified by flash chromatography to yield 30 (10 mg, 42%).
Attempted synthesis of 1’,3’-dimethyl-2-phenyl-3’,4’-dihydro-1’H -spiro-
[cyclopropane-1,2’-quinazoline]-4’-one (69)
N
N
O Under inert conditions 41 (20 mg, 0.094 mmol) was dissolved
in degassed THF (5 mL), styrene (23 µL, 0.200 mmol) and
NaH (5 mg, 0.113 mmol) were added and the reaction stirred
at room temperature for 2 days. The reaction was concen-
trated under reduced pressure, toluene (5 mL) was added and the resulting precip-
itate filtered off. The filtrate was concentrated under reduced pressure to yield an
impure oil that was a mixture of 28 and 32.
Attempted synthesis of methyl 1’,3’-dimethyl-4’-oxo-3’,4’-dihydro-1’H-
spiro[cyclopropane-1,2’-quinazoline]-2-carboxylate (70)
N
N
O
O
O
Under inert conditions 41 (20 mg, 0.094 mmol) was dissolved
in degassed THF (5 mL), methyl acrylate (18 µL, 0.200 mmol)
and NaH (5 mg, 0.113 mmol) were added and the reaction
was stirred at room temperature for 2 days. The reaction was
concentrated under reduced pressure, toluene (5 mL) was added and the resulting
precipitate filtered off. The filtrate was concentrated under reduced pressure to yield
an impure oil that was a mixture of 28 and 32.
Attempted synthesis of 2,3-diethyl 1’,3’-dimethyl-4’-oxo-3’,4’-dihydro-
1’H -spiro[cyclopropane-1,2’-quinazoline]-2,3-dicarboxylate (72)
N
N
O
OO
O
O
Under inert conditions 41 (20 mg, 0.094 mmol) was dissolved
in degassed THF (5 mL), diethyl maleate (32 µL, 0.200 mmol)
and NaH (5 mg, 0.113 mmol) were added and the reaction was
stirred at room temperature for 2 days. The reaction was con-
centrated under reduced pressure, toluene (5 mL) was added
and the resulting precipitate filtered off. The filtrate was con-
centrated under reduced pressure to yield an impure oil that was a mixture of 28
and 32.
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pent-4-en-1-amine (77)
In a pressure tube 5-bromo-1-pentene (1 g, 6.71 mmol) was dissolved in sat. methano-
lic NH3 (10 mL). The tube was sealed and heated to 90
◦C for 24 hours. The reac-
tion was allowed to cool and the solvent was removed under reduced pressure. The
residue was extracted with ethyl acetate (10 mL) and washed with sat. NaHCO3
solution (2 x 10 mL) to generate the free amine. The organic phase was washed with
H2O, brine, dried over MgSO4, filtered and the filtrate concentrated under reduced
pressure to yield 77 as a colourless oil (157 mg, 27.5%).
NH2
5
4
3
2
1 1H-NMR (CDCl3): δH 5.82 (ddt, J = 17.1, 10.0, 6.6 Hz, 1H,
C(4)H ), 5.02 (dd, J = 17.1, 1.7 Hz, 1H, C(5)Ha), 4.95 (dd, J =
10.0, 1.7 Hz, 1H, C(5)Hb), 2.61 (t, J = 7.4 Hz, 2H, C(1)H2), 2.09 (dt, J = 7.2, 6.6
Hz, 2H, C(3)H2), 1.59 (tt, J = 7.4, 7.4 Hz, 2H, C(2)H2).
2-(methylamino)-N -(pent-4-en-1-yl)benzamide (78)
N -methylisatoic anhydride (200 mg, 1.15 mmol) was dissolved in H2O (5 mL), pent-
4-en-1-amine (200 mg, 2.3 mmol) was added and the reaction was stirred at 50 ◦C for
24 hours. The reaction was allowed to cool, diluted with H2O (10 mL) and extracted
with ethyl acetate (20 mL x 2). The combined organic phases were washed with
H2O (20 mL x 2), brine (20 mL x 2), dried over MgSO4, filtered and the filtrate was
concentrated under reduced pressure to yield a colourless oil. Purification by flash
chromatography yielded 78 as a colourless oil (7.1 mg, 2.8%).
O
NH
N
H
2
6
5
4
3
1
1H-NMR (CDCl3): δH 7.98 (dd, J = 8.1, 1.7 Hz, 1H,
C(6)H ), 7.38 (ddt, J = 8.5, 7.0, 1.5 Hz, 1H, C(4)H ), 6.66
(d, J = 8.3 Hz. 1H, C(3)H ), 6.61 (t, J = 7.3 Hz, 1H,
C(5)H ), 5.78 (ddt, J = 17.1, 10.3, 6.8 Hz, 1H,
N(N )C(4)H ), 5.06 (dd, J = 17.7, 1.7 Hz, 1H, N(N )C(5)Ha), 5.01 (dd, J = 10.3, 1.3
Hz, 1H, N(N )C(5)Hb), 2.92 (s, 3H, N(2)Me), 2.87 (t, J = 8.3 Hz, 2H, N(N )C(1)H2),
2.11 (dt, J = 7.3, 7.1 Hz, 2H, N(N )C(3)H2), 1.75 (tt, J = 8.2, 7.3 Hz, 2H,
N(N )C(2)H2);
13C-NMR (CDCl3): δC 173.6 (C=O), 152.0 (C (2)), 137.1 (N(N )C (4)),
134.5 (C (4)), 132.4 (C (6)), 115.7 (N(N )C (5)), 114.0 (C (5)), 111.3 (C (1)), 110.6
(C (3)), 51.1 (N(N )C (1)), 32.4 (N(N )C (3)), 29.9 (N(2)Me), 23.1 (N(N )C (2)).
2-(N -methylformamido)-N -(pent-4-en-1-yl)benzamide (73)
Formic acid (1.15 mL, 30.42 mmol) and acetic anhydride (2.61 mL, 27.65 mmol)
were heated together for 2 hours at 55 ◦C. The reaction was allowed to cool, 78 (7.1
mg, 0.03 mmol) was added and the reaction was stirred at room temperature for
12 hours. The reaction was concentrated under reduced pressure, azeotroped with
toluene and the crude material purified by flash chromatography to yield 73 as a
clear oil (5.2 mg, 70%).
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ON
N
H
2
6
5
4
3
1
O
H
1H-NMR (CDCl3): δH 8.16 (s, 1H, N(2)C(O)H ), 7.96 (d,
J = 7.0 Hz, 1H, C(6)H ), 7.52 (t, J = 7.8 Hz, 1H, C(4)H ),
7.40 (t, J =7.5 Hz, 1H, C(5)H ), 7.22 (d, J = 7.8 Hz, 1H,
C(3)H ), 5.77 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H,
N(N )C(4)H ), 5.07 (dd, J = 17.6, 1.7 Hz, 1H, N(N )C(5)Ha), 5.02 (dd, J = 10.2, 1.7
Hz, 1H, N(N )C(5)Hb), 3.25 (s, 3H, H–14), 3.01 (t, J = 8.6 Hz, 2H, N(N )C(1)H2),
2.14 (dt, J = 13.9, 7.3 Hz, 2H, N(N )C(3)H2), 1.81 (tt, J = 7.3, 7.3 Hz, 2H,
N(N )C(2)H2);
1H-NMR (DMSO−d6): δH 8.03 (s, 1H, N(2)C(O)H ), 7.82 (d, J =
7.6 Hz, 1H, C(6)H ), 7.59 (t, J = 7.8 Hz, 1H, C(4)H ), 7.43 (t, J = 7.6 Hz, 1H,
C(5)H ), 7.38 (d, J = 7.8 Hz, 1H, C(3)H ), 5.80 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H,
N(N )C(4)H ), 5.02 (dd, J = 17.0, 1.7 Hz, 1H, N(N )C(5)Ha), 4.96 (dd, J = 10.2,
0.7 Hz, 1H, N(N )C(5)Hb), 3.10 (s, 3H, H–14), 2.64 (br s, 2H, N(N )C(1)H2), 2.03
(dt, J = 12.7, 5.7 Hz, 2H, N(N )C(3)H2), 1.55 (tt, J = 5.3, 5.3 Hz, 2H, N(N )C(2)H2).
Attempted synthesis of 2-methyl-2,10-diazatetracyclo[8.5.0.01,14.03,8]
pentadeca-3(8),4,6-trien-9-one (75)
O
N
N
A. 73 (5.2 mg, 0.021 mmol) was dissolved in DMSO−d6 (0.55 mL)
and allowed to react at room temperature for 7 days. No change
was observed by NMR spectroscopy.
B. 73 (5.2 mg, 0.021 mmol) was dissolved in CD3OD (0.55 mL)
and allowed to react at room temperature for 7 days. Solvolysis of the alkenyl amide
was observed by NMR spectrometry.
but-3-en-1-ammonium bromide (81)
In a pressure tube 4-bromobut-1-ene (0.6 g, 3.7 mmol) was dissolved in sat. methano-
lic NH3 (10 mL). The tube was sealed and heated to 90
◦C for 24 hours. The reaction
was allowed to cool and concentrated under reduced pressure to yield a white solid
that was a mixture of but-3-en-1-ammoniumbromide and 4-bromobut-1-ene (1.5:1,
0.403 g, 59.7%).
NH3 Br4
3
2
1 1H-NMR (D2O): δH 5.66 (ddt, J = 17.3, 11.5, 6.9 Hz, 1H,
C(3)H ), 5.08 (dd, J = 17.3, 1.5 Hz, 1H, C(4)Ha), 5.05 (dd, J
= 11.4, 1.5 Hz, 1H, C(4)Hb), 2.93 (t, J = 6.8 Hz, 2H, C(1)H2), 2.28 (dt, J = 15.9,
7.1 Hz, 2H, C(2)H2).
N -(but-3-enyl)-2-(methylamino)benzamide (82)
N -methylisatoic anhydride (0.66 g, 3.7 mmol) was dissolved in H2O (15 mL), but-
3-en-1-ammoniumbromide (0.403 mg, 2.65 mmol) was added and the reaction was
stirred at 50 ◦C for 24 hours. The reaction was allowed to cool, diluted with H2O
(40 mL) and extracted with ethyl acetate (50 mL x 2). The combined organic
phases were washed with H2O, brine, dried over MgSO4, filtered and the filtrate
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was concentrated under reduced pressure to give an impure brown solid. This was
dissolved in H2O (40 mL) and NaOH (0.45 g) was added to hydrolyse any remaining
N -methylisatoic anhydride. The reaction was extracted with ethyl acetate and the
organic phase was concentrated under reduced pressure to yield 82 as a brown solid
(40 mg, 7.4%).
O
NH
N
H
2
6
5
4
3
1
1H-NMR (CDCl3): δH 7.23 (t, J = 7.1 Hz, 1H, C(4)H ),
7.20 (d, J = 7.8 Hz, 1H, C(6)H ), 6.58 (d, J = 8.3 Hz. 1H,
C(3)H ), 6.49 (t, J = 7.8 Hz, 1H, C(5)H ), 5.07 (dd, J = 17.1,
1.7 Hz, 1H, N(N )C(4)Ha), 5.05 (dd, J = 10.0, 1.6 Hz, 1H,
N(N )C(4)Hb), 3.39 (dt, J = 6.6, 6.6 Hz, 2H, N(N )C(1)H2), 2.77 (s, 3H, N(2)Me),
2.28 (dt, J = 6.8, 6.8 Hz, 2H, N(N )C(2)H2).
N -(but-3-enyl)-2-(N -methylformamido)benzamide (74)
Formic acid (1.3 mL, 34.4 mmol) and acetic anhydride (2.6 mL, 27.54 mmol) were
heated together for 1 hour at 100 ◦C. The reaction was cooled, 82 (40.6 mg, 0.199
mmol) was added and the reaction mixture was stirred at room temperature for
12 hours. The reaction was concentrated under reduced pressure, azeotroped with
toluene and the crude material purified by flash chromatography to yield 74 as a
clear oil (12.9 mg, 31%).
O
N
N
H
2
6
5
4
3
1
O
H
1H-NMR (CDCl3): δH 8.22 (s, 1H, N(2)C(O)H ), 7.60 (dd, J
= 7.8, 1.8 Hz, 1H, C(6)H ), 7.49 (dt, J = 7.7, 1.4 Hz, 1H,
C(4)H ), 7.39 (dt, J = 7.7, 0.9 Hz, 1H, C(5)H ), 7.18 (dd, J
= 7.9, 1.1 Hz, 1H, C(3)H ), 5.77 (ddt, J = 17.0, 10.2, 6.9
Hz, 1H, N(N )C(3)H ), 5.13 (dd, J = 17.2, 1.3 Hz, 1H, N(N )C(4)Ha), 5.10 (dd, J
= 10.3, 1.3 Hz, 1H, N(N )C(4)Hb), 3.49 (dt, J = 6.6, 6.6 Hz, 2H, N(N )C(1)H2),
3.24 (s, 3H, H–13), 2.34 (dt, J =6.8, 6.8 Hz, 2H, N(N )C(2)H2);
13C-NMR (CDCl3):
δC 167.0 (C(1)C=O), 162.7 (N(2)C=O), 139.5 (C (2)), 135.1 (N(N )C (3)), 134.0
(C (1)), 131.6 (C (4)), 129.4 (C (6)), 128.2 (C (5)), 127.7 (C (3)), 117.9 (N(N )C (4)),
38.9 (N(N )C (1)), 33.9 (N(2)Me), 33.7 (N(N )C (2)).
Attempted synthesis of 2-methyl-2,10-diazatetracyclo[8.4.0.01,13.03,8]
tetradeca-3(8),4,6-trien-9-one (76)
O
N
N
A. In an NMR tube 74 (12.9 mg, 0.055 mmol) was dissolved in
CD3OD (0.55 mL) and allowed to react at room temperature for 7
days. 79 was observed forming by NMR spectroscopy.
B. In an NMR tube under inert conditions, 80 (20 mg, 0.09 mmol)
was dissolved in degassed CDCl3 (0.6 mL), NEt3 (5 µL, 0.036 mmol) was added and
the reaction was allowed to react at room temperature for 2 hours. Hydrolysis to
74 was observed by NMR spectroscopy.
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3-(but-3-en-1-yl)-2-(2H3)methoxy-1-methyl-2-
2H-1,3,4-trihydro
quinazolin-4-one (79)
8a
2
4
5
6
7
8
4a
1
N
N
O
D
OCD3
3
1H-NMR (CD3OD): δH 7.87 (dd, J = 7.8, 1.7 Hz, 1H, C(5)H ),
7.51 (dt, J = 7.6, 1.4 Hz, 1H, C(7)H ), 6.89 (t, J = 7.6 Hz,
1H, C(6)H ), 6.86 (d, J = 8.3 Hz, 1H, C(8)H ), 5.87 (ddt, J
= 17.1, 10.2, 6.8 Hz, 1H, N(3)C(3)H ), 5.11 (dd, J = 17.1,
1.5 Hz, 1H, N(3)C(4)Ha), 5.06 (dd, J = 10.4, 1.2 Hz, 1H, N(3)C(4)Hb), 3.86 (ddd,
J = 14.4, 8.8, 6.1 Hz, 1H, N(3)C(1)Ha), 3.45 (ddd, J = 15.1, 8.8, 6.6 Hz, 1H,
N(3)C(1)Hb), 2.54-2.39 (m, 2H, N(3)C(2)H2).
3-(but-3-en-1-yl)-1-methyl-4-oxo-3,4-dihydroquinazolin-1-ium chloride
(80)
Under inert conditions 74 (12 mg, 0.052 mmol) was dissolved in ethylchloroformate
(2 mL) and stirred at 50 ◦C for 12 hours. The reaction was concentrated under
reduced pressure to give 80 as a white solid in quantitative yield.
8a
2
4
5
6
7
8
4a
1
N
N
O
ClH
3
1H-NMR (DMSO−d6): δH 10.24 (s, 1H, C(2)H ), 8.35 (d, J
= 7.6 Hz, 1H, C(8)H ), 8.17 (t, J = 7.3 Hz, 1H, C(6)H ),
8.03 (d, J = 8.1 Hz, 1H, C(5)H ), 7.88 (t, J = 7.0 Hz,
1H, C(7)H ), 5.90-5.82 (m, 1H, N(2)C(3)H ), 5.14 (d, J =
7.0 Hz, 1H, N(2)C(4)Ha), 5.09 (d, J = 10.1 Hz, 1H, N(2)C(4)Hb), 4.17 (t, J =
6.8 Hz, 2H, N(2)C(1)H2), 4.08 (s, 3H, N(1)Me), 2.52 (dd, J = 6.8, 6.4 Hz, 2H,
N(2)C(2)H2);
13C-NMR (DMSO−d6): δC 158.2 (C (8a)), 154.5 (C (2)), 138.5 (C (4)),
137.3 (C (5)), 134.3 (N(3)C (3)), 130.5 (C (6)), 128.4 (C (8)), 120.1 (C (4a)), 119.1
(N(3)C (4)), 118.7 (C (7)), 48.1 (N(3)C (1)), 39.7 (N(1)Me), 32.6 (N(3)C (2)); HR-
ESI-MS: C13H15N2O [M]
+ m/z found 215.1182, calcd 215.1184, ∆ = -0.9 ppm.
As a dimer
Attempted synthesis of 2-(1,3-dimethyl-4-oxo-1,2,3,4-tetrahydro
quinazolin-2-ylidene)-1,3-dimethyl-1,2,3,4-tetrahydroquinazolin-4-one
(84)
N
N
O
N
N
O
Under inert conditions 41 (110 mg, 0.52 mmol) was dis-
solved in THF (2 mL), NaH (25 mg, 1.04 mmol) was added
and the reaction was stirred for 4 hours at 50 ◦C. The reac-
tion was concentrated under reduced pressure, the residue
was extracted with hot toluene and the organic phase was
concentrated under reduced pressure to give a white solid. Purification by flash
chromatography yielded 32.
1,3-dibenzyl-4-oxo-3,4-dihydroquinazolin-1-ium bromide (91)
86
4-hydroxyquinazoline (1 g, 6.84 mmol) was suspended in EtOH (40 mL), NaHCO3
(0.57 g, 6.84 mmol) and benzyl bromide (16.3 mL, 136.8 mmol) were added and the
reaction was refluxed for 2 days. The reaction was allowed to cool and concentrated
under reduced pressure. The residue was extracted with CH2Cl2 (2 x 20 mL) and
the organic phase was discarded. The remaining white solid was twice recrystalised
from EtOH and filtered. The filtrate was concentrated under reduced pressure and
purified by flash chromatography to give a white powder that was composed of
the desired product and silica. The solid was sonicated with ethyl acetate, filtered
and the filtrate concentrated under reduced pressure to give a mixed oil/precipate
residue. This was sonicated with CHCl3 (3 x 20 mL), filtered through celite and the
filtrate was concentrated under reduced pressure to give a white powder. This was
purified by flash chromatography to yield a white solid that was a mixture of 91
and 104 (1:3).
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1H-NMR (CDCl3): δH 11.88 (s, 1H, C(2)H ), 8.42 (d, J =
8.2 Hz, 1H, C(8)H ), 8.39-8.24 (m, 2H, Bn), 7.90-7.64 (m,
5H, C(6)H & Bn), 7.53 (t, 1H, C(7)H ), 7.40-7.28 (m, 5H,
C(5)H & Bn), 6.08 (s, 2H, N(3)CH2, 5.67 (s, 2H, N(1)CH2;
HR-ESI-MS: C22H19N2O [M+]
+ m/z found 327.1498, calcd
327.1497, ∆ = 0.3 ppm.
4-oxo-1,3-bis(prop-2-en-1-yl)-3,4-dihydroquinazolin-1-ium bromide (105)
A. 4-hydroxyquinazoline (1 g, 6.84 mmol) was suspended in EtOH (40 mL), NaHCO3
(0.57 g, 6.84 mmol) and allyl bromide (11.8 mL, 136.8 mmol) were added and the
reaction was refluxed for 2 days. The reaction was filtered hot, the filtrate was con-
centrated under reduced pressure and the residue was washed with ethyl acetate (3
x 20 mL). The solid was recrystalised from CH2Cl2, the precipitate was filtered and
the filtrate was concentrated under reduced pressure. The residue was extracted
with ethyl acetate (2 x 10 mL) and the organic phase was concentrated under re-
duced pressure to yield a white powder that was a mixture of 94 and 106 (4:1, 15.8
mg, 0.7%).
B. 4-hydroxyquinazoline (1 g, 6.84 mmol) was suspended in EtOH (40 mL), NaHCO3
(0.57 g, 6.84 mmol) and allyl bromide (10 mL, 115.9 mmol) were added and the re-
action was refluxed for 2 days. The reaction was cooled and left to crsytallise in
a fridge for 12 hours. The precipitate was filtered, washed with petroleum ether
(3 x 40 mL) and then hot EtOH (3 x 40 mL). The latter filtrate was concentrated
under reduced pressure, extracted with CH2Cl2 (2 x 20 mL) and concentrated under
reduced pressure. The residue was recrystallised from acetone, the precipitate was
filtered and the filtrate concentrated under reduced pressure to yield an orange oil
that was a mixture of 105 and 106 (3:1, 98.6 mg, 4.9%).
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1H-NMR (CDCl3): δH 11.43 (s, 1H, C(2)H ), 8.44 (d, J = 8.0
Hz, 1H, C(8)H ), 8.00 (t, J = 7.3 Hz, 1H, C(6)H ), 7.79 (d, J
= 9 Hz, 1H, C(5)H ), 7.77 (t, J = 7.6 Hz, 1H, C(7)H ), 6.31-
6.14 (m, 2H, N(3)C(2)H & N(1)C(2)H ), 5.68 (d, J = 18.1 Hz,
1H, N(3)C(3)Ha), 5.59 (d, J = 18.1 Hz, 1H, N(1)C(3)Ha),
5.57 (d, J = 5.1 Hz, 2H, N(3)C(1)H2), 5.50 (d, J = 10.2 Hz, 1H, N(3)C(3)Hb),
5.43 (d, J = 10.0 Hz, 1H, N(1)C(3)Hb), 5.09 (d, J = 6.2 Hz, 2H, N(1)C(1)H2);
13C-NMR (CDCl3): δC 157.1 (C (8a)), 153.7 (C (2)), 137.4 (C (4)), 136.8 (C (6)),
130.1 (C (7)), 129.5 (N(3)C (2)), 129.5 (N(1)C (2)), 129.5 (C–3), 123.0 (N(3)C (3)),
122.2 (N(1)C (3)), 120.3 (C (4a)), 118.2 (C (5)), 55.8 (N(3)C (1)), 51.4 (N(1)C (1));
HR-ESI-MS: C14H15N2O [M+]
+ m/z found 227.1181, calcd 227.1184, ∆ = -1.3 ppm.
Attempted synthesis of 2-[1-ethenyl-4-oxo-3-(prop-2-en-1-yl)-1,2,3,4-
tetrahydroquinazolin-2-ylidene]-1,3-bis(prop-2-en-1-yl)-1,2,3,4-
tetrahydroquinazolin-4-one (86)
N
N
O
N
N
O A. Under inert conditions 94 (34 mg, 0.110 mmol) was
dissolved in degassed THF (10 mL), NaH (5.3 mg, 0.133
mmol) was added and the reaction was stirred for 12 hours
at room temperature. The reaction was concentrated under
reduced pressure and purified by flash chromatography to
yield only the hydrolysis product of the starting material,
95.
B. Under inert conditions in an NMR tube, 94 (19 mg, 0.084 mmol) was dissolved
in degassed CDCl3 (0.6 mL), NEt3 (13 µL, 0.093 mmol) was added and the reaction
was allowed to proceed for 6 days at room temperature. The reaction was concen-
trated under reduced pressure and purified by flash chromatography to yield only
the hydrolysis product of the starting material, 95.
N,N -bis(prop-2-en-1-yl)-2-(N -formamido)benzamide (95)
N
H
N
O
O
H
6
5
4
3
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Rotamer A: 1H-NMR (CDCl3): δH 8.30 (s, 1H, N(2)C(O)H ),
7.64 (dd, J = 8.1, 1.7 Hz, 1H, C(6)H ), 7.48 (dt, J = 8.1, 1.7
Hz, 1H, C(5)H ), 7.41 (dt, J = 7.6, 0.7 Hz, 1H, C(4)H ), 7.22
(dd, J = 7.8, 1.2 Hz, 1H, C(3)H ), 5.9-5.8 (m, 2H, N(N )C(2)H
& N(2)C(2)H ), 5.28-5.13(m, 4H, N(N )C(3)H2 & N(2)C(3)H2),
4.28 (d, J = 6.6 Hz, 2H, N(2)C(1)H2), 3.96 (tt, J = 5.9, 1.5 Hz, 2H, N(N )C(1)H2);
13C-NMR (CDCl3): δC 166.9 (C(1)C=O), 162.5 (N(2)C=O), 137.9 (C (2)), 134.5
(C (1)), 133.6 (N(N )C (2)), 132.3 (N(2)C (2)), 131.5 (C (5)), 129.4 (C (6)), 128.9
(C (3)), 128.4 (C (4)), 119.5 (N(2)C (3)), 117.6 (N(N )C (3)), 49.3 (N(2)C (1)), 42.6
(N(N )C (1));
Rotamer B: 1H-NMR (CDCl3): δH 8.25 (s, 1H, N(2)C(O)H ), 7.58 (dd, J = 7.6, 1.7
88
Hz, 1H, C(6)H ), 7.49 (dt, J = 7.5, 1.5 Hz, 1H, C(5)H ), 7.41 (dt, J = 7.6, 0.7 Hz,
1H, C(4)H ), 7.15 (dd, J = 7.8, 1.0 Hz, 1H, C(3)H ), 5.9-5.8 (m, 2H, N(N )C(2)H
& N(2)C(2)H ), 5.28-5.13 (m, 2H, N(N )C(3)H2 & N(2)C(3)H2), 4.15 (d, J = 6.3
Hz, 2H, N(2)C(1)H2), 3.92 (tt, J = 5.8, 1.5 Hz, 2H, N(N )C(1)H2);
13C-NMR
(CDCl3): δC 167.8 (C(1)C=O), 163.8 (N(2)C=O), 136.5 (C (2)), 135.8 (C (1)), 133.7
(N(N )C (2)), 132.8 (N(2)C (2)), 131.2 (C (5)), 129.0 (C (6)), 129.0 (C (3)), 128.4
(C (4)), 120.0 (N(2)C (3)), 117.1 (N(N )C (3)), 54.3 (N(2)C (1)), 42.5 (N(N )C (1));
HR-ESI-MS: C14H16N2O2Na [M+Na]
+ m/z found 267.1108, calcd 267.1109, ∆ =
-0.4 ppm.
With organometallic compounds
Attempted synthesis of diacetoxybis(1,3,7-trimethyl-2,3,6,7-tetrahydro-
1H-purin-6-on-2-ylidene) palladium(II) (97)
N
NN
N
O
N
N N
N
O
Pd
OO
O O
In an NMR tube 23 (6 mg, 0.031 mmol) was dissolved in
CD3OD (0.55 mL), Pd(OAc)2 (7 mg, 0.031 mmol) was
added and the reaction was allowed to react for 7 days.
No change was observed by NMR spectroscopy.
diacetoxybis(1,3-dimethyl-4-oxo-1,2,3,4-tetrahydroquinazolin-2-ylidene)
palladium(II) (98)
A. 28 (20 mg, 0.104 mmol) was dissolved in CH2Cl2 (2 mL), Pd(OAc)2 (40 mg,
0.178 mmol) was added and the reaction was stirred at room temperature under
argon for three months. No change was observed by TLC analysis.
B. 28 (20 mg, 0.104 mmol) was dissolved in THF (2 mL), Pd(OAc)2 (40 mg, 0.178
mmol) was added and the reaction was stirred at room temperature under argon for
three months. No change was observed by TLC analysis.
C. 28 (40 mg, 0.208 mmol) was suspended in ethylchloroformate (1.9 mL) and the
reaction was stirred and heated at 50 ◦C for 3 hours. The reaction was concentrated
under reduced pressure, THF (2 mL), Pd(OAc)2 (93.4 mg, 0.416 mmol) and NaH
(10 mg, 0.416 mmol) were added and the reaction was stirred at room temperature
for 3 hours. The reaction was filtered, the precipitate was washed with acetonitrile
and the combined organic phases were concentrated under reduced pressure to yield
an orange solid that was predominantly composed of 32.
D. 41 (30 mg, 0.122 mmol) was dissolved in ’wet’ DMSO (5 mL), Pd(OAc)2 (13
mg, 0.058 mmol) was added and the reaction was stirred at room temperature for
12 hours. The reaction was filtered and the filtrate was concentrated under reduced
pressure to yield a white solid that was predominantly unreacted starting material.
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E. Under inert conditions 41 (30 mg, 0.122 mmol) was dissolved in THF (10 mL),
NaOAc (10 mg, 0.116 mmol) and Pd(OAc)2 (13 mg, 0.058 mmol) were added and
the reaction was stirred for 12 hours at room temperature. The reaction was concen-
trated under reduced pressure, the residue was extracted with CH2Cl2 (2 x 10 mL)
and the organic phase was concentrated under reduced pressure to give a golden oil
that was composed of starting material and 32.
F. Under inert conditions in an NMR tube, 41 (12.1 mg, 0.057 mmol) was dissolved
in degassed CDCl3 (0.6 mL), Pd(OAc)2 (11.2 mg, 0.050 mmol) was added and the
reaction was allowed to react at room temperature for 4 days. No change was ob-
served by NMR spectroscopy.
G. Under inert conditions 41 (50 mg, 0.204 mmol) was dissolved in Pd(OAc)2 (5
mL), Ag2O (92 mg, 0.395 mmol) and Pd(OAc)2 (46 mg, 0.204 mmol) were added
and the reaction was stirred at room temperature for 4 hours. The reaction was
filtered through celite and the filtrate was concentrated under reduced pressure to
give a white solid that was composed of 28 and 32.
H. Under inert conditions in an NMR tube, 41 (7 mg, 0.033 mmol) was dissolved
in degassed CDCl3 (0.55 mL), Ag2O (15.3 mg, 0.066 mmol) and Pd(OAc)2 (7.5 mg,
0.033 mmol) were added and the reaction was allowed to proceed at room temper-
ature for 24 hours. 98 was observed by NMR spectroscopy.
cistrans
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Isomer A:
1H-NMR (CDCl3): δH
8.33 (dd, J = 7.9, 1.5
Hz, 2H, C(5)H ), 7.84
(ddt, J = 7.1, 2.5, 1.7
Hz, 2H, C(7)H ), 7.57
(dd, J = 7.8, 2.5 Hz,
2H, C(8)H ), 7.55 (t, J = 7.6 Hz, 2H, C(6)H ), 4.69 (s, 6H, N(3)Me), 5.00 (s,
6H, N(1)Me), 1.95 (s, 3H, AcMe), 1.81 (s, 3H, AcMe); 13C-NMR (CDCl3): δC
199.1 (C (2)), 188.8 (AcC=O), 188.4 (AcC=O), 157.5 (C (4)), 138.8 (C (8a)), 134.1
(C (7)), 127.9 (C (5)), 126.5 (C (6)), 117.7 (C (4a)), 114.8 (C (8)), 43.5 (N(1)Me),
38.7 (N(3)Me), 22.2 (AcMe), 21.7 (AcMe).
Isomer B: 1H-NMR (solvent): δH 8.23 (dd, J =8.6, 1.5 Hz, 2H, C(5)H ), 7.68 (ddd,
J = 9.0, 7.3, 1.7 Hz, 2H, C(7)H ), 7.34 (dt, J = 7.6, 1.4 Hz, 2H, C(6)H ), 7.28 (dd, J
= 7.3, 0.9 Hz, 2H, C(8)H ), 4.68 (s, 6H, N(3)Me), 4.99 (s, 6H, N(1)Me), 1.89 (s, 3H,
AcMe), 1.70 (s, 3H, AcMe); 13C-NMR (solvent): δC 199.2 (C (2)), 183.5 (AcC=O),
176.4 (AcC=O), 157.4 (C (4)), 138.3 (C (8a)), 134.2 (C (7)), 128.3 (C (5)), 126.1
(C (6)), 117.8 (C (4a)), 114.8 (C (8)), 43.8 (N(1)Me), 38.9 (N(3)Me), 21.5 (AcMe),
21.1 (AcMe).
HR-ESI-MS: C20H19N4O2Pd [M-CH3COOH-CH3COO]
+ m/z found 451.0552, calcd
451.0548, ∆ = 0.9 ppm; C21H21N4O4Pd [M-CH3COOH-CH3COO+HCOOH]
+ m/z
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found 497.0606, calcd 497.0603, ∆ = 0.6 ppm; C24H27N4O6Pd [M+H]
+ m/z found
571.0959, calcd 571.0971, ∆ = 2.1 ppm.
Attempted synthesis of diacetoxybis((dimethylamino)(methoxy)
methylidene) palladium(II) (96)
O
N
O
N Pd
OO
O O
A. 15 (22.5 µL, 0.168 mmol) was dissolved in CH2Cl2 (2 mL)
with Pd(OAc)2 (40 mg, 0.178 mmol) and stirred at room tem-
perature under argon for three months. No change was observed
by TLC analysis.
B. 15 (22.5 µL, 0.168 mmol) was dissolved in THF (2 mL) with Pd(OAc)2 (40 mg,
0.178 mmol) and stirred at room temperature under argon for three months. No
change was observed by TLC analysis.
Attempted synthesis of diacetoxy(1,3-dimethyl-4-oxo-1,2,3,4-tetrahydro
quinazolin-2-ylidene)(pyridinium-1-yl)palladium(II) chloride (107)
N
N
N
O
Pd
OO
O O
Cl
41 (30 mg, 0.122 mmol) was dissolved in pyridine (3 mL),
K2CO3 (128 mg, 0.927 mmol) and Pd(OAc)2 (55 mg,
0.245 mmol) were added and the reaction was refluxed
for 3 hours. The reaction was filtered through celite and
the filtrate was concentrated under reduced pressure to
yield a yellow solid that was composed of 28 and 32.
2-(1,3-dimethyl-4-oxo-1,2,3,4-tetrahydroquinazolin-2-ylidene)-1,3-
dimethyl-1,2,3,4-tetrahydroquinazolin-4-one (84)
A. Under inert conditions 41 (50 mg, 0.204 mmol) was dissolved in CH2Cl2 (5
mL), Ag2O (23 mg, 0.102 mmol) was added and the reaction was stirred at room
temperature for 20 minutes. The reaction was centrifuged and the supernatant was
removed and concentrated under reduced pressure to yield a white solid that was
composed of 28 and 32.
B. Under inert conditions 41 (50 mg, 0.204 mmol) was dissolved in CH2Cl2 (5
mL), Ag2O (138 mg, 0.612 mmol) was added and the reaction was stirred at room
temperature for 10 hours. The reaction mixture was filtered through celite, washed
with ethyl acetate and the combined organic phases were concentrated under reduced
pressure to yield a white solid that was composed of 28 and 32.
C. Under inert conditions in an NMR tube, 41 (7.1 mg, 0.034 mmol) was dissolved
in degassed CDCl3 (0.55 mL), Ag2O (15.6 mg, 0.067 mmol) was added and the
reaction was allowed to proceed at room temperature for 2 hours. 84 was observed
by NMR spectroscopy.
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1H-NMR (CDCl3): δH 7.87 (d, J
= 7.9 Hz, 2H , C(5)H ), 7.38 (t,
J = 7.8 Hz, 2H, C(7)H ), 6.81 (t,
J = 7.7 Hz, 2H, C(6)H ), 6.65 (d,
J = 8.3 Hz, 2H, C(8)H ), 3.13 (s,
6H, N(3)Me), 3.00 (s, 6H,
N(1)Me); 13C-NMR (CDCl3): δC 161.8 (C (4)), 142.0 (C (8a)), 133.9 (C (7)), 128.3
(C (5)), 118.7 (C (6)), 112.2 (C (8)), 111.7 (C (4a)), 106.8 (C (2)), 32.3 (N(3)Me), 34.9
(N(1)Me); HR-ESI-MS: C21H24N4O3K [M+MeOH+K]
+ m/z found 419.1497, calcd
419.1485, ∆ = -2.6 ppm; C21H24N4O3Na [M+MeOH+Na]
+ m/z found 403.1755,
calcd 403.1746, ∆ = 2.2 ppm; C21H23N4O3 [M+MeO]
− m/z found 379.1768, calcd
379.1770, ∆ = -0.5 ppm.
Attempted synthesis of 2-[4-oxo-1,3-bis(prop-2-en-1-yl)-1,2,3,4-tetra
hydroquinazolin-2-ylidene]-1,3-bis(prop-2-en-1-yl)-1,2,3,4-tetrahydro
quinazolin-4-one (86)
N
N
O
N
N
O Under inert conditions in an NMR tube, 94 (20 mg, 0.065
mmol) was dissolved in degassed CDCl3 (0.6 mL), Ag2O
(30.1 mg, 0.130 mmol) was added and the reaction was al-
lowed to proceed at room temperature for 48 hours. 101
was observed by NMR spectroscopy.
2-hydroxy-1,3-bis(prop-2-en-1-yl)-1,2,3,4-tetrahydroquinazolin-4-one
(101)
N
N
O
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H8
7
6
5
4
3
21
4a
8a
1H-NMR (CDCl3): δH 7.92 (dd, J = 7.8, 1.4 Hz, 1H, C(5)H ),
7.36 (dt, J = 8.7, 1.5 Hz, 1H, C(7)H ), 6.84 (t, J = 7.5 Hz,
1H, C(6)H ), 6.73 (d, J = 8.4 Hz, 1H, C(8)H ), 6.02-5.83 (m, 2H,
N(3)C(2)H & N(1)C(2)H ), 5.77 (s, 1H, C(2)H ), 5.40-5.16 (m, 4H,
N(3)C(3)H2 & N(1)C(3)H2), 4.72-4.67 (m, 1H, N(3)C(1)Ha), 4.09
(dd, J = 8.7, 5.0 Hz, 2H, N(1)C(1)H2), 3.86 (dd, J = 15.9, 7.1 Hz, 1H, N(3)C(1)Hb);
13C-NMR (CDCl3): δC 161.4 (C (4)), 143.4 (C (8a)), 133.9 (C (7)), 133.1 (N(1)C (2)),
133.0 (N(3)C (2)), 128.8 (C (5)), 118.8 (C (6)), 118.0 (N(3)C (3)), 117.9 (N(1)C (3)),
114.8 (C (4a)), 112.7 (C (8)), 89.8 (C (2)), 50.5 (N(1)C (1)), 46.4 (N(3)C (1)); HR-
ESI-MS: C14H17N2O2 [M+H]
+ m/z found 245.1294, calcd 245.1289, ∆ = 2.1 ppm.
Attempted synthesis of diacetoxybis(4-oxo-1,3-bis(prop-2-en-1-yl)-
1,2,3,4-tetrahydroquinazolin-2-ylidene)palladium(II) (108)
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Under inert conditions in an NMR tube, 94 (20 mg,
0.065 mmol) was dissolved in degassed CDCl3 (0.6 mL),
aG2o (30.1 mg, 0.130 mmol) and Pd(OAc)2 (14.6 mg,
0.065 mmol) were added and the reaction was allowed to
proceed at room temperature for 24 hours. No change
was observed by NMR spectroscopy.
Species observed by mass spectrometry from DMFDMA kinetic studies
N,N -dimethyl(2H)formamide (53)
N
O
D
HR-ESI-MS: C3H6DNONa [M+Na]
+ m/z found 97.0491, calcd 97.0488,
∆ = 3.1 ppm
[(dimethylamino)(2H)methylidene]dimethylazanium (55)
N
N
H
HR-ESI-MS: C5H13N2 [M]
+ m/z found 101.1082, calcd 101.1079, ∆ =
3.0 ppm
6.2 Kinetic studies
Kinetic studies were recorded on a Varian DirectDrive 600 (600 MHz for 1H) equipped
with a Varian inverse-detected triple-resonance HCN cold probe operating at 25K.
Variable temperature studies were performed on a Varian Unity Inova 300 (300 Mhz
for 1H). T1 analyses of 23, 28 and 41 were completed to ensure the pulse delay used
in the kinetic studies was of a sufficient length to allow complete relaxation between
pulses. pw90 calibrations were performed for all kinetic experiments involving 23,
but not for other analytes due to their faster half-life. 0.55 mL of deuterated sol-
vent was used in each experiment. The experiment timing began upon first contact
between the analyte and the solvent. The time for each data point represents the
midpoint of acquisition of each FID. The integrals for all carbon-bound proton reso-
nances of the analyte were defined and the sum of these normalised to a value of 100.
In the case of the kinetic studies of 15, only the amide acetal and dimethylamine
resonances were integrated. The value reported is the integral of the formyl, amidine
or amide acetal resonance, depending on analyte, and represents the contribution
of this resonance to the total integral of 100. Data was analysed and models were
fitted using OriginPro 8 (OriginLab Corp.) software, version 8.0724.
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6.2.1 Imidazole-based models
Setup
Table 6.1 Composition of 23 kinetic experiments
Experiment Solvent Source of 23 m na [23]b
(mg) (mmol) (mmol/L)
PGKC4-4J CD3OD PGKC4-4I 6.0 0.0306 55.60
PGKC4K-I CD3OD PGKC4-4I 5.4 0.0275 50.04
PGKC4K-3 CD3OD PGKC4-4I 7.6 0.0387 70.43
PGKC4K-5 CD3OD PGKC5-3C/PGKC5-3F 1.1 0.0056 10.19
PGKC4K-6 CD3OD PGKC5-3C/PGKC5-3F 3.2 0.0163 29.65
PGKC4K-7 CD3OD PGKC5-3C/PGKC5-3F 9.7 0.0494 89.89
PGKC4K-11 CD3OD PGKC5-3C/PGKC5-3F 8.2 0.0418 75.99
PGKC5-3I CD3OD PGKC5-3I 6.0 0.0306 55.60
PGKC5K-1 CD3OD PGKC5-3I 2.3 0.0117 21.31
PGKC5K-2 CD3OD PGKC5-3I 4.3 0.0219 39.85
PGKC5K-3 CD3OD PGKC5-3I 6.4 0.0326 59.31
PGKC5K-5 CD3OD PGKC5-3I 9.0 0.0459 83.40
PGKC5K-6 CD3OD PGKC5-3I 11.6 0.0591 107.5
PGKC5K-7c CD3OD PGKC5-3I 6.4 0.0326 59.31
PGKC5K-8 CD3OD PGKC5-3I 13.8 0.0703 127.9
PGKC5K-14 D2O PGKC5-3I 6.0 0.0306 55.60
PGKC5K-17 D2O PGKC5-3I 6.0 0.0306 55.60
aMolar mass of 23 = 196.2 g/mol
bTotal volume of solvent = 0.55 mL
cTriethylamine (9.7 µL, 0.0695 mmol) also added
Kinetic studies analysed by Initial-Rate method
Experiment parameters:
• acqusition time (at) = 10 seconds
• delay d1 (d1) = 60 seconds
• pulse width (pw) = pw90
• number of transients (nt) = 4
• pre-acquisition delay (pad) = 1520.5 seconds between acquisitions
• 13 acquisitions obtained
Analysis:
• integral of formyl proton resonance plotted against time
• linear model applied (as visualised on the graph and summarised in subsequent
table)
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Figure 6.1 Formyl proton resonance with time in experiment PGKC4K-1
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Figure 6.2 Formyl proton resonance with time in experiment PGKC4K-3
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Figure 6.3 Formyl proton resonance with time in experiment PGKC4K-5
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Figure 6.4 Formyl proton resonance with time in experiment PGKC4K-6
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Figure 6.5 Formyl proton resonance with time in experiment PGKC4K-7
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Figure 6.6 Formyl proton resonance with time in experiment PGKC5K-1
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Figure 6.7 Formyl proton resonance with time in experiment PGKC5K-2
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Figure 6.8 Formyl proton resonance with time in experiment PGKC5K-3
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Figure 6.9 Formyl proton resonance with time in experiment PGKC5K-5
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Figure 6.10 Formyl proton resonance with time in experiment PGKC5K-6
99
0 50 100 150 200 250 300 350 400
7.8
8.0
8.2
8.4
8.6
8.8
9.0
9.2
In
te
gr
al
 o
f t
he
 fo
rm
yl
 p
ro
to
n 
re
so
na
nc
e
Time (minutes)
Figure 6.11 Formyl proton resonance with time in experiment PGKC5K-7
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Figure 6.12 Formyl proton resonance with time in experiment PGKC5K-8
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Table 6.2 Analysis of 23 kinetic experiments by Initial-Rate method
Experiment [23] Initial rate r2
(mmol/L) (/min)
PGKC4K-1 50.04 -0.00203 0.928
PGKC4K-3 70.43 -0.00167 0.818
PGKC4K-5 10.19 -a -
PGKC4K-6 29.65 - -
PGKC4K-7 89.89 - -
PGKC5K-1 21.31 -0.00224 0.848
PGKC5K-2 39.85 -0.00234 0.960
PGKC5K-3 59.31 -0.00279 0.925
PGKC5K-5 83.40 -0.00283 0.989
PGKC5K-6 107.5 -0.00290 0.982
PGKC5K-7 59.31b -0.00321 0.984
PGKC5K-8 127.9 -0.00296 0.953
aAn exponential decay curve could not be fitted to this data
b[Triethylamine] = 126.4 mmol/L
101
Kinetic studies analysed by Half-Life method
Experiment parameters:
• at = 4.1 seconds
• d1 = 0 seconds
• pw = pw60
• nt = 64
• acquisitions acquired at irregular intervals over a period of days
• continued until complete absence of formyl proton resonance observed
Analysis:
• integral of formyl proton resonance plotted against time
• exponential model applied (as visualised on the graph and summarised in
subsequent table)
0 2 0 4 0 6 0 8 0 1 0 0 1 2 00
1
2
3
4
5
6
7
8
Inte
gra
l of 
the
 for
myl
 pro
ton
 res
ona
nce
T i m e  ( h o u r s )
Figure 6.13 Formyl proton resonance with time in experiment PGKC4-4J
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Figure 6.14 Formyl proton resonance with time in experiment PGKC4K-11
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Figure 6.15 Formyl proton resonance with time in experiment PGKC5-3I
103
0 5 1 0 1 5 2 0 2 5 3 00
1
2
3
4
5
6
7
8
Inte
gra
l of 
the
 for
myl
 pro
ton
 res
ona
nce
T i m e  ( h o u r s )
Figure 6.16 Formyl proton resonance with time in experiment PGKC5K-14
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Figure 6.17 Formyl proton resonance with time in experiment PGKC5K-17
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Table 6.3 Analysis of 23 kinetic experiments by Half-Life method
Experiment [23] Exponential rate r2 Half-life
(mmol/L) (h)
PGKC4-4J 55.60 -0.0245 0.999 28.2
PGKC4K-11 75.99 -a - -
PGKC5-3I 55.60 -0.0550 0.976 12.6
PGKC5K-14 55.60 -0.0577 0.999 12.0
PGKC5K-17 55.60 -0.0193 0.997 36.0
aAn exponential decay curve could not be fitted to this data
Variable-temperature studies
Setup:
• 23 (5.5 mg, 0.028 mmol) was dissolved in the nominated NMR solvent (0.55
mL)
• allowed to exchange for 5 hours prior to acquisitions
Experiment parameters:
• at = 3.4 seconds
• d1 = 0 seconds
• pw = pw60
• nt = 64
• acquisitions obtained at room temperature and -50 ◦C
Results:
• CDCl3- no difference in spectra acquired at the different temperatures
• CD3OD- no difference in spectra acquired at the different temperatures
6.2.2 Benzene-based models
Setup
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Kinetic studies analysed by Initial-Rate method
Experiment parameters:
• at = 10 seconds
• d1 = 10 seconds
• pw = pw90
• nt = 12
• pad = 1560 seconds between acquisitions
• 13 acquisitions obtained
Analysis:
• integral of formyl proton resonance plotted against time
• linear model applied (as visualised on the graph and summarised in subsequent
table)
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Figure 6.18 Formyl proton resonance with time in experiment PGKC5K-18
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Figure 6.19 Formyl proton resonance with time in experiment PGKC5K-19
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Figure 6.20 Formyl proton resonance with time in experiment PGKC5K-20
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Figure 6.21 Formyl proton resonance with time in experiment PGKC5K-21
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Figure 6.22 Formyl proton resonance with time in experiment PGKC5K-22
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Figure 6.23 Formyl proton resonance with time in experiment PGKC5K-23
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Figure 6.24 Formyl proton resonance with time in experiment PGKC5K-24
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Figure 6.25 Formyl proton resonance with time in experiment PGKC5K-25
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Figure 6.26 Formyl proton resonance with time in experiment PGKC5K-26
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Figure 6.27 Formyl proton resonance with time in experiment PGKC5K-27
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Figure 6.28 Formyl proton resonance with time in experiment PGKC5K-28
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Figure 6.29 Formyl proton resonance with time in experiment PGKC5K-33
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Figure 6.30 Formyl proton resonance with time in experiment PGKC5K-34
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Table 6.5 Analysis of 28 kinetic experiments by Initial-Rate method
Experiment [23] Additive [Additive] Initial rate r2
(mmol/L) (mmol/L) (/min)
PGKC5K-18 56.76 -0.0047 0.999
PGKC5K-19 56.76 NEt3 161.6 -0.0131 0.999
PGKC5K-20 56.76 CD3COOD 160.7 -
a -
PGKC5K-21 113.5 -0.0078 0.999
PGKC5K-22 170.3 -0.0087 0.999
PGKC5K-23 56.76 NEt3 215.1 -0.0134 0.999
PGKC5K-24 56.76 NEt3 108.2 -0.0129 0.999
PGKC5K-25 94.59 -0.0070 0.999
PGKC5K-26 75.67 -0.0070 0.999
PGKC5K-27 37.84 -0.0051 0.999
PGKC5K-28 56.76 NEt3 56.64 -0.0130 0.999
PGKC5K-33 56.76 KOH 213.9 -0.0108 0.999
PGKC5K-34 56.76 DMAP 107.2 -0.0254 0.999
aAn exponential decay curve could not be fitted to this data
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Kinetic studies analysed by Half-Life method
Experiment parameters:
• at = 4.1 seconds
• d1 = 0 seconds
• pw = pw60
• nt = 64
• acquisitions acquired at irregular intervals over a period of days
• continued until complete absence of formyl proton resonance observed
Analysis:
• integral of formyl proton resonance plotted against time
• exponential model applied (as visualised on the graph and summarised in
subsequent table)
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Figure 6.31 Formyl proton resonance with time in experiment PGKC5K-11
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Figure 6.32 Formyl proton resonance with time in experiment PGKC5K-15
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Figure 6.33 Formyl proton resonance with time in experiment PGKC5K-16
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Table 6.6 Analysis of 28 kinetic experiments by Half-Life method
Experiment [28] Exponential rate r2 Half-life
(mmol/L) (h)
PGKC5K-11 56.76 -0.0515 0.988 13.5
PGKC5K-15 56.76 -0.4107 0.999 1.7
PGKC5K-16 56.76 -0.0550 0.999 1.5
6.2.3 Quinazolinium-based models
Setup
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Kinetic studies analysed by Half-Life method
Experiment parameters:
• at = 10 seconds
• d1 = 10 seconds
• pw = pw90
• nt = 12
• pad = 0 seconds between acquisitions
• 13 acquisitions obtained
Analysis:
• integral of amidine proton resonance plotted against time
• exponential model applied (as visualised on the graph and summarised in
subsequent table)
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Figure 6.34 Amidine proton resonance with time in experiment PGKC5K-36
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Figure 6.35 Amidine proton resonance with time in experiment PGKC5K-38
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Figure 6.36 Amidine proton resonance with time in experiment PGKC5K-49
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Figure 6.37 Amidine proton resonance with time in experiment PGKC5K-50
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Figure 6.38 Amidine proton resonance with time in experiment PGKC5K-51
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Figure 6.39 Amidine proton resonance with time in experiment PGKC5K-52
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Figure 6.40 Amidine proton resonance with time in experiment PGKC5K-54
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Figure 6.41 Amidine proton resonance with time in experiment PGKC5K-59
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Figure 6.42 Amidine proton resonance with time in experiment PGKC5K-61
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Figure 6.43 Amidine proton resonance with time in experiment PGKC5K-62
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Figure 6.44 Amidine proton resonance with time in experiment PGKC5K-63
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Figure 6.45 Amidine proton resonance with time in experiment PGKC5K-64
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Figure 6.46 Amidine proton resonance with time in experiment PGKC5K-65
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Figure 6.47 Amidine proton resonance with time in experiment PGKC5K-66
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Figure 6.48 Amidine proton resonance with time in experiment PGKC7-K-1
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Figure 6.49 Amidine proton resonance with time in experiment PGKC7-K-5
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Figure 6.50 Amidine proton resonance with time in experiment PGKC7-K-10
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Figure 6.51 Amidine proton resonance with time in experiment PGKC7-K-11
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Figure 6.52 Amidine proton resonance with time in experiment PGKC7-K-12
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Figure 6.53 Amidine proton resonance with time in experiment PGKC7-K-13
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Figure 6.54 Amidine proton resonance with time in experiment PGKC7-K-14
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Figure 6.55 Amidine proton resonance with time in experiment PGKC7-K-15
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Figure 6.56 Amidine proton resonance with time in experiment PGKC7-K-16
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Table 6.8 Analysis of 41 kinetic experiments by Half-Life method
Experiment [41] Additive [Additive] Exponential r2 Half-life
(mmol/L) (mmol/L) rate (min)
PGKC5K-36 54.53 -0.0087 0.999 80.0
PGKC5K-38 51.93 -a - -
PGKC5K-49 8.66 -0.0547 0.997 12.7
PGKC5K-50 18.18 -0.0324 0.998 21.4
PGKC5K-51 25.97 -0.0270 0.999 25.7
PGKC5K-52 34.62 -0.0231 0.995 30.0
PGKC5K-54 17.31 NEt3 1043 -
b - -
PGKC5K-59 17.31 CD3COOD 26.79 -
a - -
PGKC5K-61 44.14 -0.0202 0.999 34.2
PGKC5K-62 17.31 NEt3 0.4220 -0.0837 0.999 8.3
PGKC5K-63 17.31 NEt3 0.2110 -0.0553 0.996 12.5
PGKC5K-64 17.31 NEt3 0.6331 -0.0770 0.999 9.0
PGKC5K-65 17.31 NEt3 0.8441 -0.1214 0.997 5.7
PGKC5K-66 17.31 NEt3 1.0551 -0.1102 0.997 6.3
PGKC7-K-1 17.31 NEt3 0.0992 -0.0649 0.999 10.7
PGKC7-K-5 17.31 NEt3 0.4958 -0.0873 0.997 7.9
PGKC7-K-10 17.31 NEt3 1.0027 -0.1518 0.999 4.6
PGKC7-K-11 17.31 NEt3 0.2534 -0.0760 0.998 9.1
PGKC7-K-12 17.31 NEt3 0.0551 -0.0622 0.999 11.1
PGKC7-K-13 17.31 NEt3 0.0100 -0.0553 0.999 12.5
PGKC7-K-14 17.31 NEt3 0.0250 -0.0586 0.999 11.8
PGKC7-K-15 17.31 NEt3 0.0751 -0.0602 0.999 11.5
PGKC7-K-16 17.31 NEt3 0.7514 -0.1163 0.999 6.0
aAn exponential decay curve could be fitted to this data
bAn exponential decay curve could not be accurately fitted to this data
6.2.4 DMFDMA
Setup
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DMFDMA kinetic studies
Experiment parameters:
• at = 10 seconds
• d1 = 10 seconds
• pw = pw90
• nt = 12
• pad = 0 seconds between acquisitions
• 13 acquisitions obtained
Analysis:
• integral of amide-acetal proton resonance plotted against time
• exponential model applied (as visualised on the graph and summarised in
subsequent table)
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Figure 6.57 Amide-acetal proton resonance with time in experiment PGKC7-
DMFDMA-8
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Figure 6.58 Amide-acetal proton resonance with time in experiment PGKC7-
DMFDMA-9
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Figure 6.59 Amide-acetal proton resonance with time in experiment PGKC7-
DMFDMA-10
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Figure 6.60 Amide-acetal proton resonance with time in experiment PGKC7-
DMFDMA-11
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Figure 6.61 Amide-acetal proton resonance with time in experiment PGKC7-
DMFDMA-12
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Figure 6.62 Amide-acetal proton resonance with time in experiment PGKC7-
DMFDMA-13
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Figure 6.63 Amide-acetal proton resonance with time in experiment PGKC7-
DMFDMA-14
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Spectra
Selected spectra of key compounds
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1H-NMR spectrum of 23 (600 MHz, CDCl3)
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13C-NMR spectrum of 23 (150 MHz, CDCl3)
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1H-NMR spectrum of 28 (500 MHz, CDCl3)
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